1st level
|
2nd level
|
3rd level
|
4th level
|
5th level
|
Contents
|
A
|
|
|
|
|
Alimentary tract and metabolism
|
|
A01
|
|
|
|
Stomatological preparations
|
|
|
A01A
|
|
|
Stomatological preparations
|
|
|
|
A01AA
|
|
Caries prophylactic agents
|
|
|
|
|
A01AA01
|
Sodium fluoride
|
|
|
|
|
A01AA02
|
Sodium monofluorophosphate
|
|
|
|
|
A01AA03
|
Olaflur
|
|
|
|
|
A01AA04
|
Stannous fluoride
|
|
|
|
|
A01AA30
|
Combinations
|
|
|
|
|
A01AA51
|
Sodium fluoride, combinations
|
|
|
|
A01AB
|
|
Anti-infectives and antiseptics for local oral treatment
|
|
|
|
|
A01AB02
|
Hydrogen peroxide
|
|
|
|
|
A01AB03
|
Chlorhexidine
|
|
|
|
|
A01AB04
|
Amphotericin B
|
|
|
|
|
A01AB05
|
Polynoxylin
|
|
|
|
|
A01AB06
|
Domiphen
|
|
|
|
|
A01AB07
|
Oxyquinoline
|
|
|
|
|
A01AB08
|
Neomycin
|
|
|
|
|
A01AB09
|
Miconazole
|
|
|
|
|
A01AB10
|
Natamycin
|
|
|
|
|
A01AB11
|
Various
|
|
|
|
|
A01AB12
|
Hexetidine
|
|
|
|
|
A01AB13
|
Tetracycline
|
|
|
|
|
A01AB14
|
Benzoxonium chloride
|
|
|
|
|
A01AB15
|
Tibezonium iodide
|
|
|
|
|
A01AB16
|
Mepartricin
|
|
|
|
|
A01AB17
|
Metronidazole
|
|
|
|
|
A01AB18
|
Clotrimazole
|
|
|
|
|
A01AB19
|
Sodium perborate
|
|
|
|
|
A01AB21
|
Chlortetracycline
|
|
|
|
|
A01AB22
|
Doxycycline
|
|
|
|
|
A01AB23
|
Minocycline
|
|
|
|
A01AC
|
|
Corticosteroids for local oral treatment
|
|
|
|
|
A01AC01
|
Triamcinolone
|
|
|
|
|
A01AC02
|
Dexamethasone
|
|
|
|
|
A01AC03
|
Hydrocortisone
|
|
|
|
|
A01AC54
|
Prednisolone, combinations
|
|
|
|
A01AD
|
|
Other agents for local oral treatment
|
|
|
|
|
A01AD01
|
Epinephrine
|
|
|
|
|
A01AD02
|
Benzydamine
|
|
|
|
|
A01AD05
|
Acetylsalicylic acid
|
|
|
|
|
A01AD06
|
Adrenalone
|
|
|
|
|
A01AD07
|
Amlexanox
|
|
|
|
|
A01AD08
|
Becaplermin
|
|
|
|
|
A01AD11
|
Various
|
|
A02
|
|
|
|
Drugs for acid related disorders
|
|
|
A02A
|
|
|
Antacids
|
|
|
|
A02AA
|
|
Magnesium compounds
|
|
|
|
|
A02AA01
|
Magnesium carbonate
|
|
|
|
|
A02AA02
|
Magnesium oxide
|
|
|
|
|
A02AA03
|
Magnesium peroxide
|
|
|
|
|
A02AA04
|
Magnesium hydroxide
|
|
|
|
|
A02AA05
|
Magnesium silicate
|
|
|
|
|
A02AA10
|
Combinations
|
|
|
|
A02AB
|
|
Aluminium compounds
|
|
|
|
|
A02AB01
|
Aluminium hydroxide
|
|
|
|
|
A02AB02
|
Algeldrate
|
|
|
|
|
A02AB03
|
Aluminium phosphate
|
|
|
|
|
A02AB04
|
Dihydroxialumini sodium carbonate
|
|
|
|
|
A02AB05
|
Aluminium acetoacetate
|
|
|
|
|
A02AB06
|
Aloglutamol
|
|
|
|
|
A02AB07
|
Aluminium glycinate
|
|
|
|
|
A02AB10
|
Combinations
|
|
|
|
A02AC
|
|
Calcium compounds
|
|
|
|
|
A02AC01
|
Calcium carbonate
|
|
|
|
|
A02AC02
|
Calcium silicate
|
|
|
|
|
A02AC10
|
Combinations
|
|
|
|
A02AD
|
|
Combinations and complexes of aluminium, calcium and magnesium compounds
|
|
|
|
|
A02AD01
|
Ordinary salt combinations
|
|
|
|
|
A02AD02
|
Magaldrate
|
|
|
|
|
A02AD03
|
Almagate
|
|
|
|
|
A02AD04
|
Hydrotalcite
|
|
|
|
|
A02AD05
|
Almasilate
|
|
|
|
A02AF
|
|
Antacids with antiflatulents
|
|
|
|
|
A02AF01
|
Magaldrate and antiflatulents
|
|
|
|
|
A02AF02
|
Ordinary salt combinations and antiflatulents
|
|
|
|
A02AG
|
|
Antacids with antispasmodics
|
|
|
|
|
|
Empty
|
|
|
|
A02AH
|
|
Antacids with sodium bicarbonate
|
|
|
|
|
|
Empty
|
|
|
|
A02AX
|
|
Antacids, other combinations
|
|
|
|
|
|
Empty
|
|
|
A02B
|
|
|
Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
|
|
|
|
A02BA
|
|
H2-receptor antagonists
|
|
|
|
|
A02BA01
|
Cimetidine
|
|
|
|
|
A02BA02
|
Ranitidine
|
|
|
|
|
A02BA03
|
Famotidine
|
|
|
|
|
A02BA04
|
Nizatidine
|
|
|
|
|
A02BA05
|
Niperotidine
|
|
|
|
|
A02BA06
|
Roxatidine
|
|
|
|
|
A02BA07
|
Ranitidine bismuth citrate
|
|
|
|
|
A02BA08
|
Lafutidine
|
|
|
|
|
A02BA51
|
Cimetidine, combinations
|
|
|
|
|
A02BA53
|
Famotidine, combinations
|
|
|
|
A02BB
|
|
Prostaglandins
|
|
|
|
|
A02BB01
|
Misoprostol
|
|
|
|
|
A02BB02
|
Enprostil
|
|
|
|
A02BC
|
|
Proton pump inhibitors
|
|
|
|
|
A02BC01
|
Omeprazole
|
|
|
|
|
A02BC02
|
Pantoprazole
|
|
|
|
|
A02BC03
|
Lansoprazole
|
|
|
|
|
A02BC04
|
Rabeprazole
|
|
|
|
|
A02BC05
|
Esomeprazole
|
|
|
|
|
A02BC06
|
Dexlansoprazole
|
|
|
|
A02BD
|
|
Combinations for eradication of Helicobacter pylori
|
|
|
|
|
A02BD01
|
Omeprazole, amoxicillin and metronidazole
|
|
|
|
|
A02BD02
|
Lansoprazole, tetracycline and metronidazole
|
|
|
|
|
A02BD03
|
Lansoprazole, amoxicillin and metronidazole
|
|
|
|
|
A02BD04
|
Pantoprazole, amoxicillin and clarithromycin
|
|
|
|
|
A02BD05
|
Omeprazole, amoxicillin and clarithromycin
|
|
|
|
|
A02BD06
|
Esomeprazole, amoxicillin and clarithromycin
|
|
|
|
|
A02BD07
|
Lansoprazole, amoxicillin and clarithromycin
|
|
|
|
|
A02BD08
|
Bismuth subcitrate, tetracycline and metronidazole
|
|
|
|
A02BX
|
|
Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
|
|
|
|
|
A02BX01
|
Carbenoxolone
|
|
|
|
|
A02BX02
|
Sucralfate
|
|
|
|
|
A02BX03
|
Pirenzepine
|
|
|
|
|
A02BX04
|
Methiosulfonium chloride
|
|
|
|
|
A02BX05
|
Bismuth subcitrate
|
|
|
|
|
A02BX06
|
Proglumide
|
|
|
|
|
A02BX07
|
Gefarnate
|
|
|
|
|
A02BX08
|
Sulglicotide
|
|
|
|
|
A02BX09
|
Acetoxolone
|
|
|
|
|
A02BX10
|
Zolimidine
|
|
|
|
|
A02BX11
|
Troxipide
|
|
|
|
|
A02BX12
|
Bismuth subnitrate
|
|
|
|
|
A02BX13
|
Alginic acid
|
|
|
|
|
A02BX51
|
Carbenoxolone, combinations excluding psycholeptics
|
|
|
|
|
A02BX71
|
Carbenoxolone, combinations with psycholeptics
|
|
|
|
|
A02BX77
|
Gefarnate, combinations with psycholeptics
|
|
|
A02X
|
|
|
Other drugs for acid related disorders
|
|
|
|
|
|
Empty
|
|
A03
|
|
|
|
Drugs for functional gastrointestinal disorders
|
|
|
A03A
|
|
|
Drugs for functional gastrointestinal disorders
|
|
|
|
A03AA
|
|
Synthetic anticholinergics, esters with tertiary amino group
|
|
|
|
|
A03AA01
|
Oxyphencyclimine
|
|
|
|
|
A03AA03
|
Camylofin
|
|
|
|
|
A03AA04
|
Mebeverine
|
|
|
|
|
A03AA05
|
Trimebutine
|
|
|
|
|
A03AA06
|
Rociverine
|
|
|
|
|
A03AA07
|
Dicycloverine
|
|
|
|
|
A03AA08
|
Dihexyverine
|
|
|
|
|
A03AA09
|
Difemerine
|
|
|
|
|
A03AA30
|
Piperidolate
|
|
|
|
A03AB
|
|
Synthetic anticholinergics, quaternary ammonium compounds
|
|
|
|
|
A03AB01
|
Benzilone
|
|
|
|
|
A03AB02
|
Glycopyrronium
|
|
|
|
|
A03AB03
|
Oxyphenonium
|
|
|
|
|
A03AB04
|
Penthienate
|
|
|
|
|
A03AB05
|
Propantheline
|
|
|
|
|
A03AB06
|
Otilonium bromide
|
|
|
|
|
A03AB07
|
Methantheline
|
|
|
|
|
A03AB08
|
Tridihexethyl
|
|
|
|
|
A03AB09
|
Isopropamide
|
|
|
|
|
A03AB10
|
Hexocyclium
|
|
|
|
|
A03AB11
|
Poldine
|
|
|
|
|
A03AB12
|
Mepenzolate
|
|
|
|
|
A03AB13
|
Bevonium
|
|
|
|
|
A03AB14
|
Pipenzolate
|
|
|
|
|
A03AB15
|
Diphemanil
|
|
|
|
|
A03AB16
|
(2-benzhydryloxyethyl)diethyl-methylammonium iodide
|
|
|
|
|
A03AB17
|
Tiemonium iodide
|
|
|
|
|
A03AB18
|
Prifinium bromide
|
|
|
|
|
A03AB19
|
Timepidium bromide
|
|
|
|
|
A03AB21
|
Fenpiverinium
|
|
|
|
|
A03AB53
|
Oxyphenonium, combinations
|
|
|
|
A03AC
|
|
Synthetic antispasmodics, amides with tertiary amines
|
|
|
|
|
A03AC02
|
Dimethylaminopropionylphenothiazine
|
|
|
|
|
A03AC04
|
Nicofetamide
|
|
|
|
|
A03AC05
|
Tiropramide
|
|
|
|
A03AD
|
|
Papaverine and derivatives
|
|
|
|
|
A03AD01
|
Papaverine
|
|
|
|
|
A03AD02
|
Drotaverine
|
|
|
|
|
A03AD30
|
Moxaverine
|
|
|
|
A03AE
|
|
Serotonin receptor antagonists
|
|
|
|
|
A03AE01
|
Alosetron
|
|
|
|
|
A03AE03
|
Cilansetron
|
|
|
|
A03AX
|
|
Other drugs for functional gastrointestinal disorders
|
|
|
|
|
A03AX01
|
Fenpiprane
|
|
|
|
|
A03AX02
|
Diisopromine
|
|
|
|
|
A03AX03
|
Chlorbenzoxamine
|
|
|
|
|
A03AX04
|
Pinaverium
|
|
|
|
|
A03AX05
|
Fenoverine
|
|
|
|
|
A03AX06
|
Idanpramine
|
|
|
|
|
A03AX07
|
Proxazole
|
|
|
|
|
A03AX08
|
Alverine
|
|
|
|
|
A03AX09
|
Trepibutone
|
|
|
|
|
A03AX10
|
Isometheptene
|
|
|
|
|
A03AX11
|
Caroverine
|
|
|
|
|
A03AX12
|
Phloroglucinol
|
|
|
|
|
A03AX13
|
Silicones
|
|
|
|
|
A03AX30
|
Trimethyldiphenylpropylamine
|
|
|
|
|
A03AX58
|
Alverine, combinations
|
|
|
A03B
|
|
|
Belladonna and derivatives, plain
|
|
|
|
A03BA
|
|
Belladonna alkaloids, tertiary amines
|
|
|
|
|
A03BA01
|
Atropine
|
|
|
|
|
A03BA03
|
Hyoscyamine
|
|
|
|
|
A03BA04
|
Belladonna total alkaloids
|
|
|
|
A03BB
|
|
Belladonna alkaloids, semisynthetic, quaternary ammonium compounds
|
|
|
|
|
A03BB01
|
Butylscopolamine
|
|
|
|
|
A03BB02
|
Methylatropine
|
|
|
|
|
A03BB03
|
Methylscopolamine
|
|
|
|
|
A03BB04
|
Fentonium
|
|
|
|
|
A03BB05
|
Cimetropium bromide
|
|
|
A03C
|
|
|
Antispasmodics in combination with psycholeptics
|
|
|
|
A03CA
|
|
Synthetic anticholinergic agents in combination with psycholeptics
|
|
|
|
|
A03CA01
|
Isopropamide and psycholeptics
|
|
|
|
|
A03CA02
|
Clidinium and psycholeptics
|
|
|
|
|
A03CA03
|
Oxyphencyclimine and psycholeptics
|
|
|
|
|
A03CA04
|
Otilonium bromide and psycholeptics
|
|
|
|
|
A03CA05
|
Glycopyrronium and psycholeptics
|
|
|
|
|
A03CA06
|
Bevonium and psycholeptics
|
|
|
|
|
A03CA07
|
Ambutonium and psycholeptics
|
|
|
|
|
A03CA08
|
Diphemanil and psycholeptics
|
|
|
|
|
A03CA30
|
Emepronium and psycholeptics
|
|
|
|
|
A03CA34
|
Propantheline and psycholeptics
|
|
|
|
A03CB
|
|
Belladonna and derivatives in combination with psycholeptics
|
|
|
|
|
A03CB01
|
Methylscopolamine and psycholeptics
|
|
|
|
|
A03CB02
|
Belladonna total alkaloids and psycholeptics
|
|
|
|
|
A03CB03
|
Atropine and psycholeptics
|
|
|
|
|
A03CB04
|
Methylhomatropine and psycholeptics
|
|
|
|
|
A03CB31
|
Hyoscyamine and psycholeptics
|
|
|
|
A03CC
|
|
Other antispasmodics in combination with psycholeptics
|
|
|
|
|
|
empty
|
|
|
A03D
|
|
|
Antispasmodics in combination with analgesics
|
|
|
|
A03DA
|
|
Synthetic anticholinergic agents in combination with analgesics
|
|
|
|
|
A03DA01
|
Tropenzilone and analgesics
|
|
|
|
|
A03DA02
|
Pitofenone and analgesics
|
|
|
|
|
A03DA03
|
Bevonium and analgesics
|
|
|
|
|
A03DA04
|
Ciclonium and analgesics
|
|
|
|
|
A03DA05
|
Camylofin and analgesics
|
|
|
|
|
A03DA06
|
Trospium and analgesics
|
|
|
|
|
A03DA07
|
Tiemonium iodide and analgesics
|
|
|
|
A03DB
|
|
Belladonna and derivatives in combination with analgesics
|
|
|
|
|
A03DB04
|
Butylscopolamine and analgesics
|
|
|
|
A03DC
|
|
Other antispasmodics in combination with analgesics
|
|
|
|
|
|
empty
|
|
|
A03E
|
|
|
Antispasmodics and anticholinergics in combination with other drugs
|
|
|
|
A03EA
|
|
Antispasmodics, psycholeptics and analgesics in combination
|
|
|
|
|
|
empty
|
|
|
|
A03ED
|
|
Antispasmodics in combination with other drugs
|
|
|
|
|
|
empty
|
|
|
A03F
|
|
|
Propulsives
|
|
|
|
A03FA
|
|
Propulsives
|
|
|
|
|
A03FA01
|
Metoclopramide
|
|
|
|
|
A03FA02
|
Cisapride
|
|
|
|
|
A03FA03
|
Domperidone
|
|
|
|
|
A03FA04
|
Bromopride
|
|
|
|
|
A03FA05
|
Alizapride
|
|
|
|
|
A03FA06
|
Clebopride
|
|
A04
|
|
|
|
Antiemetics and antinauseants
|
|
|
A04A
|
|
|
Antiemetics and antinauseants
|
|
|
|
A04AA
|
|
Serotonin (5-HT3) antagonists
|
|
|
|
|
A04AA01
|
Ondansetron
|
|
|
|
|
A04AA02
|
Granisetron
|
|
|
|
|
A04AA03
|
Tropisetron
|
|
|
|
|
A04AA04
|
Dolasetron
|
|
|
|
|
A04AA05
|
Palonosetron
|
|
|
|
A04AD
|
|
Other antiemetics
|
|
|
|
|
A04AD01
|
Scopolamine
|
|
|
|
|
A04AD02
|
Cerium oxalate
|
|
|
|
|
A04AD04
|
Chlorobutanol
|
|
|
|
|
A04AD05
|
Metopimazine
|
|
|
|
|
A04AD10
|
Dronabinol
|
|
|
|
|
A04AD11
|
Nabilone
|
|
|
|
|
A04AD12
|
Aprepitant
|
|
|
|
|
A04AD13
|
Casopitant
|
|
|
|
|
A04AD51
|
Scopolamine, combinations
|
|
|
|
|
A04AD54
|
Chlorobutanol, combinations
|
|
A05
|
|
|
|
Bile and liver therapy
|
|
|
A05A
|
|
|
Bile therapy
|
|
|
|
A05AA
|
|
Bile acid preparations
|
|
|
|
|
A05AA01
|
Chenodeoxycholic acid
|
|
|
|
|
A05AA02
|
Ursodeoxycholic acid
|
|
|
|
|
A05AA03
|
Cholic acid
|
|
|
|
A05AB
|
|
Preparations for biliary tract therapy
|
|
|
|
|
A05AB01
|
Nicotinyl methylamide
|
|
|
|
A05AX
|
|
Other drugs for bile therapy
|
|
|
|
|
A05AX01
|
Piprozolin
|
|
|
|
|
A05AX02
|
Hymecromone
|
|
|
|
|
A05AX03
|
Cyclobutyrol
|
|
|
A05B
|
|
|
Liver therapy, lipotropics
|
|
|
|
A05BA
|
|
Liver therapy
|
|
|
|
|
A05BA01
|
Arginine glutamate
|
|
|
|
|
A05BA03
|
Silymarin
|
|
|
|
|
A05BA04
|
Citiolone
|
|
|
|
|
A05BA05
|
Epomediol
|
|
|
|
|
A05BA06
|
Ornithine oxoglutarate
|
|
|
|
|
A05BA07
|
Tidiacic arginine
|
|
|
|
|
A05BA08
|
Glycyrrhizic acid (glycyrrhizin)
|
|
|
A05C
|
|
|
Drugs for bile therapy and lipotropics in combination
|
|
|
|
|
|
Empty
|
|
A06
|
|
|
|
Drugs for constipation
|
|
|
A06A
|
|
|
Drugs for constipation
|
|
|
|
A06AA
|
|
Softeners, emollients
|
|
|
|
|
A06AA01
|
Liquid paraffin
|
|
|
|
|
A06AA02
|
Docusate sodium
|
|
|
|
|
A06AA51
|
Liquid paraffin, combinations
|
|
|
|
A06AB
|
|
Contact laxatives
|
|
|
|
|
A06AB01
|
Oxyphenisatine
|
|
|
|
|
A06AB02
|
Bisacodyl
|
|
|
|
|
A06AB03
|
Dantron
|
|
|
|
|
A06AB04
|
Phenolphthalein
|
|
|
|
|
A06AB05
|
Castor oil
|
|
|
|
|
A06AB06
|
Senna glycosides
|
|
|
|
|
A06AB07
|
Cascara
|
|
|
|
|
A06AB08
|
Sodium picosulfate
|
|
|
|
|
A06AB09
|
Bisoxatin
|
|
|
|
|
A06AB20
|
Contact laxatives in combination
|
|
|
|
|
A06AB30
|
Contact laxatives in combination with belladonna alkaloids
|
|
|
|
|
A06AB52
|
Bisacodyl, combinations
|
|
|
|
|
A06AB53
|
Dantron, combinations
|
|
|
|
|
A06AB56
|
Senna glycosides, combinations
|
|
|
|
|
A06AB57
|
Cascara, combinations
|
|
|
|
|
A06AB58
|
Sodium picosulfate, combinations
|
|
|
|
A06AC
|
|
Bulk-forming laxatives
|
|
|
|
|
A06AC01
|
Ispaghula (psylla seeds)
|
|
|
|
|
A06AC02
|
Ethulose
|
|
|
|
|
A06AC03
|
Sterculia
|
|
|
|
|
A06AC05
|
Linseed
|
|
|
|
|
A06AC06
|
Methylcellulose
|
|
|
|
|
A06AC07
|
Triticum (wheat fibre)
|
|
|
|
|
A06AC08
|
Polycarbophil calcium
|
|
|
|
|
A06AC51
|
Ispaghula, combinations
|
|
|
|
|
A06AC53
|
Sterculia, combinations
|
|
|
|
|
A06AC55
|
Linseed, combinations
|
|
|
|
A06AD
|
|
Osmotically acting laxatives
|
|
|
|
|
A06AD01
|
Magnesium carbonate
|
|
|
|
|
A06AD02
|
Magnesium oxide
|
|
|
|
|
A06AD03
|
Magnesium peroxide
|
|
|
|
|
A06AD04
|
Magnesium sulfate
|
|
|
|
|
A06AD10
|
Mineral salts in combination
|
|
|
|
|
A06AD11
|
Lactulose
|
|
|
|
|
A06AD12
|
Lactitol
|
|
|
|
|
A06AD13
|
Sodium sulfate
|
|
|
|
|
A06AD14
|
Pentaerithrityl
|
|
|
|
|
A06AD15
|
Macrogol
|
|
|
|
|
A06AD16
|
Mannitol
|
|
|
|
|
A06AD17
|
Sodium phosphate
|
|
|
|
|
A06AD18
|
Sorbitol
|
|
|
|
|
A06AD19
|
Magnesium citrate
|
|
|
|
|
A06AD21
|
Sodium tartrate
|
|
|
|
|
A06AD61
|
Lactulose, combinations
|
|
|
|
|
A06AD65
|
Macrogol, combinations
|
|
|
|
A06AG
|
|
Enemas
|
|
|
|
|
A06AG01
|
Sodium phosphate
|
|
|
|
|
A06AG02
|
Bisacodyl
|
|
|
|
|
A06AG03
|
Dantron, including combinations
|
|
|
|
|
A06AG04
|
Glycerol
|
|
|
|
|
A06AG06
|
Oil
|
|
|
|
|
A06AG07
|
Sorbitol
|
|
|
|
|
A06AG10
|
Docusate sodium, including combinations
|
|
|
|
|
A06AG11
|
Laurilsulfate, including combinations
|
|
|
|
|
A06AG20
|
Combinations
|
|
|
|
A06AH
|
|
Peripheral opioid receptor antagonists
|
|
|
|
|
A06AH01
|
Methylnaltrexone bromide
|
|
|
|
|
A06AH02
|
Alvimopan
|
|
|
|
A06AX
|
|
Other drugs for constipation
|
|
|
|
|
A06AX01
|
Glycerol
|
|
|
|
|
A06AX02
|
Carbon dioxide producing drugs
|
|
|
|
|
A06AX03
|
Lubiprostone
|
|
|
|
|
A06AX04
|
Linaclotide
|
|
|
|
|
A06AX05
|
Prucalopride
|
|
|
|
|
A06AX06
|
Tegaserod
|
|
A07
|
|
|
|
Antidiarrheals, intestinal anti-inflammatory/anti-infective agents
|
|
|
A07A
|
|
|
Intestinal anti-infectives
|
|
|
|
A07AA
|
|
Antibiotics
|
|
|
|
|
A07AA01
|
Neomycin
|
|
|
|
|
A07AA02
|
Nystatin
|
|
|
|
|
A07AA03
|
Natamycin
|
|
|
|
|
A07AA04
|
Streptomycin
|
|
|
|
|
A07AA05
|
Polymyxin B
|
|
|
|
|
A07AA06
|
Paromomycin
|
|
|
|
|
A07AA07
|
Amphotericin B
|
|
|
|
|
A07AA08
|
Kanamycin
|
|
|
|
|
A07AA09
|
Vancomycin
|
|
|
|
|
A07AA10
|
Colistin
|
|
|
|
|
A07AA11
|
Rifaximin
|
|
|
|
|
A07AA12
|
Fidaxomicin
|
|
|
|
|
A07AA51
|
Neomycin, combinations
|
|
|
|
|
A07AA54
|
Streptomycin, combinations
|
|
|
|
A07AB
|
|
Sulfonamides
|
|
|
|
|
A07AB02
|
Phthalylsulfathiazole
|
|
|
|
|
A07AB03
|
Sulfaguanidine
|
|
|
|
|
A07AB04
|
Succinylsulfathiazole
|
|
|
|
A07AC
|
|
Imidazole derivatives
|
|
|
|
|
A07AC01
|
Miconazole
|
|
|
|
A07AX
|
|
Other intestinal anti-infectives
|
|
|
|
|
A07AX01
|
Broxyquinoline
|
|
|
|
|
A07AX02
|
Acetarsol
|
|
|
|
|
A07AX03
|
Nifuroxazide
|
|
|
|
|
A07AX04
|
Nifurzide
|
|
|
A07B
|
|
|
Intestinal adsorbents
|
|
|
|
A07BA
|
|
Charcoal preparations
|
|
|
|
|
A07BA01
|
Medicinal charcoal
|
|
|
|
|
A07BA51
|
Medicinal charcoal, combinations
|
|
|
|
A07BB
|
|
Bismuth preparations
|
|
|
|
|
|
empty
|
|
|
|
A07BC
|
|
Other intestinal adsorbents
|
|
|
|
|
A07BC01
|
Pectin
|
|
|
|
|
A07BC02
|
Kaolin
|
|
|
|
|
A07BC03
|
Crospovidone
|
|
|
|
|
A07BC04
|
Attapulgite
|
|
|
|
|
A07BC05
|
Diosmectite
|
|
|
|
|
A07BC30
|
Combinations
|
|
|
|
|
A07BC54
|
Attapulgite, combinations
|
|
|
A07C
|
|
|
Electrolytes with carbohydrates
|
|
|
|
A07CA
|
|
Oral rehydration salt formulations
|
|
|
|
|
|
human ATC classification.
|
|
|
A07D
|
|
|
Antipropulsives
|
|
|
|
A07DA
|
|
Antipropulsives
|
|
|
|
|
A07DA01
|
Diphenoxylate
|
|
|
|
|
A07DA02
|
Opium
|
|
|
|
|
A07DA03
|
Loperamide
|
|
|
|
|
A07DA04
|
Difenoxin
|
|
|
|
|
A07DA05
|
Loperamide oxide
|
|
|
|
|
A07DA52
|
Morphine, combinations
|
|
|
|
|
A07DA53
|
Loperamide, combinations
|
|
|
A07E
|
|
|
Intestinal anti-inflammatory agents
|
|
|
|
A07EA
|
|
Corticosteroids acting locally
|
|
|
|
|
A07EA01
|
Prednisolone
|
|
|
|
|
A07EA02
|
Hydrocortisone
|
|
|
|
|
A07EA03
|
Prednisone
|
|
|
|
|
A07EA04
|
Betamethasone
|
|
|
|
|
A07EA05
|
Tixocortol
|
|
|
|
|
A07EA06
|
Budesonide
|
|
|
|
|
A07EA07
|
Beclometasone
|
|
|
|
A07EB
|
|
Antiallergic agents, excluding corticosteroids
|
|
|
|
|
A07EB01
|
Cromoglicic acid
|
|
|
|
A07EC
|
|
Aminosalicylic acid and similar agents
|
|
|
|
|
A07EC01
|
Sulfasalazine
|
|
|
|
|
A07EC02
|
Mesalazine
|
|
|
|
|
A07EC03
|
Olsalazine
|
|
|
|
|
A07EC04
|
Balsalazide
|
|
|
A07F
|
|
|
Antidiarrheal micro-organisms
|
|
|
|
A07FA
|
|
Antidiarrheal micro-organisms
|
|
|
|
|
A07FA01
|
Lactic acid producing organisms
|
|
|
|
|
A07FA02
|
Saccharomyces boulardii
|
|
|
|
|
A07FA51
|
Lactic acid producing organisms, combinations
|
|
|
A07X
|
|
|
Other antidiarrheals
|
|
|
|
A07XA
|
|
Other antidiarrheals
|
|
|
|
|
A07XA01
|
Albumin tannate
|
|
|
|
|
A07XA02
|
Ceratonia
|
|
|
|
|
A07XA03
|
Calcium compounds
|
|
|
|
|
A07XA04
|
Racecadotril
|
|
|
|
|
A07XA51
|
Albumin tannate, combinations
|
|
A08
|
|
|
|
Antiobesity preparations, excluding diet products
|
|
|
A08A
|
|
|
Antiobesity preparations, excluding diet products
|
|
|
|
A08AA
|
|
Centrally acting antiobesity products
|
|
|
|
|
A08AA01
|
Phentermine
|
|
|
|
|
A08AA02
|
Fenfluramine
|
|
|
|
|
A08AA03
|
Amfepramone
|
|
|
|
|
A08AA04
|
Dexfenfluramine
|
|
|
|
|
A08AA05
|
Mazindol
|
|
|
|
|
A08AA06
|
Etilamfetamine
|
|
|
|
|
A08AA07
|
Cathine
|
|
|
|
|
A08AA08
|
Clobenzorex
|
|
|
|
|
A08AA09
|
Mefenorex
|
|
|
|
|
A08AA10
|
Sibutramine
|
|
|
|
|
A08AA56
|
Ephedrine, combinations
|
|
|
|
A08AB
|
|
Peripherally acting antiobesity products
|
|
|
|
|
A08AB01
|
Orlistat
|
|
|
|
A08AX
|
|
Other antiobesity drugs
|
|
|
|
|
A08AX01
|
Rimonabant
|
|
A09
|
|
|
|
Digestives,including enzymes
|
|
|
A09A
|
|
|
Digestives, including enzymes
|
|
|
|
A09AA
|
|
Enzyme preparations
|
|
|
|
|
A09AA01
|
Diastase
|
|
|
|
|
A09AA02
|
Multienzymes (lipase, protease, etc.)
|
|
|
|
|
A09AA03
|
Pepsin
|
|
|
|
|
A09AA04
|
Tilactase
|
|
|
|
A09AB
|
|
Acid preparations
|
|
|
|
|
A09AB01
|
Glutamic acid hydrochloride
|
|
|
|
|
A09AB02
|
Betaine hydrochloride
|
|
|
|
|
A09AB03
|
Hydrochloric acid
|
|
|
|
|
A09AB04
|
Citric acid
|
|
|
|
A09AC
|
|
Enzyme and acid preparations, combinations
|
|
|
|
|
A09AC01
|
Pepsin and acid preparations
|
|
|
|
|
A09AC02
|
Multienzymes and acid preparations
|
|
A10
|
|
|
|
Drugs used in diabetes
|
|
|
A10A
|
|
|
Insulins and analogues
|
|
|
|
A10AB
|
|
Insulins and analogues for injection, fast-acting
|
|
|
|
|
A10AB01
|
Insulin (human)
|
|
|
|
|
A10AB02
|
Insulin (beef)
|
|
|
|
|
A10AB03
|
Insulin (pork)
|
|
|
|
|
A10AB04
|
Insulin lispro
|
|
|
|
|
A10AB05
|
Insulin aspart
|
|
|
|
|
A10AB06
|
Insulin glulisine
|
|
|
|
|
A10AB30
|
Combinations
|
|
|
|
A10AC
|
|
Insulins and analogues for injection, intermediate-acting
|
|
|
|
|
A10AC01
|
Insulin (human)
|
|
|
|
|
A10AC02
|
Insulin (beef)
|
|
|
|
|
A10AC03
|
Insulin (pork)
|
|
|
|
|
A10AC04
|
Insulin lispro
|
|
|
|
|
A10AC30
|
Combinations
|
|
|
|
A10AD
|
|
Insulins and analogues for injection, intermediate-acting combined with fast-acting
|
|
|
|
|
A10AD01
|
Insulin (human)
|
|
|
|
|
A10AD02
|
Insulin (beef)
|
|
|
|
|
A10AD03
|
Insulin (pork)
|
|
|
|
|
A10AD04
|
Insulin lispro
|
|
|
|
|
A10AD05
|
Insulin aspart
|
|
|
|
|
A10AD30
|
Combinations
|
|
|
|
A10AE
|
|
Insulins and analogues for injection, long-acting
|
|
|
|
|
A10AE01
|
Insulin (human)
|
|
|
|
|
A10AE02
|
Insulin (beef)
|
|
|
|
|
A10AE03
|
Insulin (pork)
|
|
|
|
|
A10AE04
|
Insulin glargine
|
|
|
|
|
A10AE05
|
Insulin detemir
|
|
|
|
|
A10AE30
|
Combinations
|
|
|
|
A10AF
|
|
Insulins and analogues for inhalation
|
|
|
|
|
A10AF01
|
Insulin (human)
|
|
|
A10B
|
|
|
Blood glucose lowering drugs, excluding insulins
|
|
|
|
A10BA
|
|
Biguanides
|
|
|
|
|
A10BA01
|
Phenformin
|
|
|
|
|
A10BA02
|
Metformin
|
|
|
|
|
A10BA03
|
Buformin
|
|
|
|
A10BB
|
|
Sulfonamides, urea derivatives
|
|
|
|
|
A10BB01
|
Glibenclamide
|
|
|
|
|
A10BB02
|
Chlorpropamide
|
|
|
|
|
A10BB03
|
Tolbutamide
|
|
|
|
|
A10BB04
|
Glibornuride
|
|
|
|
|
A10BB05
|
Tolazamide
|
|
|
|
|
A10BB06
|
Carbutamide
|
|
|
|
|
A10BB07
|
Glipizide
|
|
|
|
|
A10BB08
|
Gliquidone
|
|
|
|
|
A10BB09
|
Gliclazide
|
|
|
|
|
A10BB10
|
Metahexamide
|
|
|
|
|
A10BB11
|
Glisoxepide
|
|
|
|
|
A10BB12
|
Glimepiride
|
|
|
|
|
A10BB31
|
Acetohexamide
|
|
|
|
A10BC
|
|
Sulfonamides (heterocyclic)
|
|
|
|
|
A10BC01
|
Glymidine
|
|
|
|
A10BD
|
|
Combinations of oral blood glucose lowering drugs
|
|
|
|
|
A10BD01
|
Phenformin and sulfonamides
|
|
|
|
|
A10BD02
|
Metformin and sulfonamides
|
|
|
|
|
A10BD03
|
Metformin and rosiglitazone
|
|
|
|
|
A10BD04
|
Glimepiride and rosiglitazone
|
|
|
|
|
A10BD05
|
Metformin and pioglitazone
|
|
|
|
|
A10BD06
|
Glimepiride and pioglitazone
|
|
|
|
|
A10BD07
|
Metformin and sitagliptin
|
|
|
|
|
A10BD08
|
Metformin and vildagliptin
|
|
|
|
|
A10BD09
|
Pioglitazone and alogliptin
|
|
|
|
|
A10BD10
|
Metformin and saxagliptin
|
|
|
|
|
A10BD11
|
Metformin and linagliptin
|
|
|
|
|
A10BD12
|
Pioglitazone and sitagliptin
|
|
|
|
|
A10BD13
|
Metformin and alogliptin
|
|
|
|
A10BF
|
|
Alpha glucosidase inhibitors
|
|
|
|
|
A10BF01
|
Acarbose
|
|
|
|
|
A10BF02
|
Miglitol
|
|
|
|
|
A10BF03
|
Voglibose
|
|
|
|
A10BG
|
|
Thiazolidinediones
|
|
|
|
|
A10BG01
|
Troglitazone
|
|
|
|
|
A10BG02
|
Rosiglitazone
|
|
|
|
|
A10BG03
|
Pioglitazone
|
|
|
|
A10BH
|
|
Dipeptidyl peptidase 4 (DPP-4) inhibitors
|
|
|
|
|
A10BH01
|
Sitagliptin
|
|
|
|
|
A10BH02
|
Vildagliptin
|
|
|
|
|
A10BH03
|
Saxagliptin
|
|
|
|
|
A10BH04
|
Alogliptin
|
|
|
|
|
A10BH05
|
Linagliptin
|
|
|
|
|
A10BH51
|
Sitagliptin and simvastatin
|
|
|
|
A10BX
|
|
Other blood glucose lowering drugs, excluding insulins
|
|
|
|
|
A10BX01
|
Guar gum
|
|
|
|
|
A10BX02
|
Repaglinide
|
|
|
|
|
A10BX03
|
Nateglinide
|
|
|
|
|
A10BX04
|
Exenatide
|
|
|
|
|
A10BX05
|
Pramlintide
|
|
|
|
|
A10BX06
|
Benfluorex
|
|
|
|
|
A10BX07
|
Liraglutide
|
|
|
|
|
A10BX08
|
Mitiglinide
|
|
|
|
|
A10BX09
|
Dapagliflozin
|
|
|
A10X
|
|
|
Other drugs used in diabetes
|
|
|
|
A10XA
|
|
Aldose reductase inhibitors
|
|
|
|
|
A10XA01
|
Tolrestat
|
|
A11
|
|
|
|
Vitamins
|
|
|
A11A
|
|
|
Multivitamins, combinations
|
|
|
|
A11AA
|
|
Multivitamins with minerals
|
|
|
|
|
A11AA01
|
Multivitamins and iron
|
|
|
|
|
A11AA02
|
Multivitamins and calcium
|
|
|
|
|
A11AA03
|
Multivitamins and other minerals, including combinations
|
|
|
|
|
A11AA04
|
Multivitamins and trace elements
|
|
|
|
A11AB
|
|
Multivitamins, other combinations
|
|
|
|
|
|
empty
|
|
|
A11B
|
|
|
Multivitamins, plain
|
|
|
|
A11BA
|
|
Multivitamins, plain
|
|
|
|
|
|
empty
|
|
|
A11C
|
|
|
Vitamin A and D, including combinations of the two
|
|
|
|
A11CA
|
|
Vitamin A, plain
|
|
|
|
|
A11CA01
|
Retinol (vitamin A)
|
|
|
|
|
A11CA02
|
Betacarotene
|
|
|
|
A11CB
|
|
Vitamin A and D in combination
|
|
|
|
|
|
empty
|
|
|
|
A11CC
|
|
Vitamin D and analogues
|
|
|
|
|
A11CC01
|
Ergocalciferol
|
|
|
|
|
A11CC02
|
Dihydrotachysterol
|
|
|
|
|
A11CC03
|
Alfacalcidol
|
|
|
|
|
A11CC04
|
Calcitriol
|
|
|
|
|
A11CC05
|
Colecalciferol
|
|
|
|
|
A11CC06
|
Calcifediol
|
|
|
|
|
A11CC20
|
Combinations
|
|
|
A11D
|
|
|
Vitamin B1, plain and in combination with vitamin B6 and B12
|
|
|
|
A11DA
|
|
Vitamin B1, plain
|
|
|
|
|
A11DA01
|
Thiamine (vitamin B1)
|
|
|
|
|
A11DA02
|
Sulbutiamine
|
|
|
|
|
A11DA03
|
Benfotiamine
|
|
|
|
A11DB
|
|
Vitamin B1 in combination with vitamin B6 and/or vitamin B12
|
|
|
|
|
|
empty
|
|
|
A11E
|
|
|
Vitamin B-complex, including combinations
|
|
|
|
A11EA
|
|
Vitamin B-complex, plain
|
|
|
|
|
|
empty
|
|
|
|
A11EB
|
|
Vitamin B-complex with vitamin C
|
|
|
|
|
|
empty
|
|
|
|
A11EC
|
|
Vitamin B-complex with minerals
|
|
|
|
|
|
empty
|
|
|
|
A11ED
|
|
Vitamin B-complex with anabolic steroids
|
|
|
|
|
|
empty
|
|
|
|
A11EX
|
|
Vitamin B-complex, other combinations
|
|
|
|
|
|
empty
|
|
|
A11G
|
|
|
Ascorbic acid (vitamin C), including combinations
|
|
|
|
A11GA
|
|
Ascorbic acid (vitamin C), plain
|
|
|
|
|
A11GA01
|
Ascorbic acid (vitamin C)
|
|
|
|
A11GB
|
|
Ascorbic acid (vitamin C), combinations
|
|
|
|
|
A11GB01
|
Ascorbic acid (vitamin C) and calcium
|
|
|
A11H
|
|
|
Other plain vitamin preparations
|
|
|
|
A11HA
|
|
Other plain vitamin preparations A11HA01 Nicotinamide
|
|
|
|
|
A11HA02
|
Pyridoxine (vitamin B6)
|
|
|
|
|
A11HA03
|
Tocopherol (vitamin E)
|
|
|
|
|
A11HA04
|
Riboflavin (vitamin B2)
|
|
|
|
|
A11HA05
|
Biotin
|
|
|
|
|
A11HA06
|
Pyridoxal phosphate
|
|
|
|
|
A11HA07
|
Inositol
|
|
|
|
|
A11HA08
|
Tocofersolan
|
|
|
|
|
A11HA30
|
Dexpanthenol
|
|
|
|
|
A11HA31
|
Calcium pantothenate
|
|
|
|
|
A11HA32
|
Pantethine
|
|
|
A11J
|
|
|
Other vitamin products, combinations
|
|
|
|
A11JA
|
|
Combinations of vitamins
|
|
|
|
|
|
empty
|
|
|
|
A11JB
|
|
Vitamins with minerals
|
|
|
|
|
|
empty
|
|
|
|
A11JC
|
|
Vitamins, other combinations
|
|
|
|
|
|
empty
|
|
A12
|
|
|
|
Mineral supplements
|
|
|
A12A
|
|
|
Calcium
|
|
|
|
A12AA
|
|
Calcium
|
|
|
|
|
A12AA01
|
Calcium phosphate
|
|
|
|
|
A12AA02
|
Calcium glubionate
|
|
|
|
|
A12AA03
|
Calcium gluconate
|
|
|
|
|
A12AA04
|
Calcium carbonate
|
|
|
|
|
A12AA05
|
Calcium lactate
|
|
|
|
|
A12AA06
|
Calcium lactate gluconate
|
|
|
|
|
A12AA07
|
Calcium chloride
|
|
|
|
|
A12AA08
|
Calcium glycerylphosphate
|
|
|
|
|
A12AA09
|
Calcium citrate lysine complex
|
|
|
|
|
A12AA10
|
Calcium glucoheptonate
|
|
|
|
|
A12AA11
|
Calcium pangamate
|
|
|
|
|
A12AA12
|
Calcium acetate anhydrous
|
|
|
|
|
A12AA20
|
Calcium (different salts in combination)
|
|
|
|
|
A12AA30
|
Calcium laevulate
|
|
|
|
A12AX
|
|
Calcium, combinations with vitamin D and/or other drugs
|
|
|
|
|
|
empty
|
|
|
A12B
|
|
|
Potassium
|
|
|
|
A12BA
|
|
Potassium
|
|
|
|
|
A12BA01
|
Potassium chloride
|
|
|
|
|
A12BA02
|
Potassium citrate
|
|
|
|
|
A12BA03
|
Potassium hydrogentartrate
|
|
|
|
|
A12BA04
|
Potassium hydrogencarbonate
|
|
|
|
|
A12BA05
|
Potassium gluconate
|
|
|
|
|
A12BA30
|
Combinations
|
|
|
|
|
A12BA51
|
Potassium chloride, combinations
|
|
|
A12C
|
|
|
Other mineral supplements
|
|
|
|
A12CA
|
|
Sodium
|
|
|
|
|
A12CA01
|
Sodium chloride
|
|
|
|
|
A12CA02
|
Sodium sulfate
|
|
|
|
A12CB
|
|
Zinc
|
|
|
|
|
A12CB01
|
Zinc sulfate
|
|
|
|
|
A12CB02
|
Zinc gluconate
|
|
|
|
|
A12CB03
|
Zinc protein complex
|
|
|
|
A12CC
|
|
Magnesium
|
|
|
|
|
A12CC01
|
Magnesium chloride
|
|
|
|
|
A12CC02
|
Magnesium sulfate
|
|
|
|
|
A12CC03
|
Magnesium gluconate
|
|
|
|
|
A12CC04
|
Magnesium citrate
|
|
|
|
|
A12CC05
|
Magnesium aspartate
|
|
|
|
|
A12CC06
|
Magnesium lactate
|
|
|
|
|
A12CC07
|
Magnesium levulinate
|
|
|
|
|
A12CC08
|
Magnesium pidolate
|
|
|
|
|
A12CC09
|
Magnesium orotate
|
|
|
|
|
A12CC10
|
Magnesium oxide
|
|
|
|
|
A12CC30
|
Magnesium (different salts in combination)
|
|
|
|
A12CD
|
|
Fluoride
|
|
|
|
|
A12CD01
|
Sodium fluoride
|
|
|
|
|
A12CD02
|
Sodium monofluorophosphate
|
|
|
|
|
A12CD51
|
Fluoride, combinations
|
|
|
|
A12CE
|
|
Selenium
|
|
|
|
|
A12CE01
|
Sodium selenate
|
|
|
|
|
A12CE02
|
Sodium selenite
|
|
|
|
A12CX
|
|
Other mineral products
|
|
|
|
|
|
empty
|
|
A13
|
|
|
|
Tonics
|
|
|
A13A
|
|
|
Tonics
|
|
|
|
|
|
empty
|
|
A14
|
|
|
|
Anabolic agents for systemic use
|
|
|
A14A
|
|
|
Anabolic steroids
|
|
|
|
A14AA
|
|
Androstan derivatives
|
|
|
|
|
A14AA01
|
Androstanolone
|
|
|
|
|
A14AA02
|
Stanozolol
|
|
|
|
|
A14AA03
|
Metandienone
|
|
|
|
|
A14AA04
|
Metenolone
|
|
|
|
|
A14AA05
|
Oxymetholone
|
|
|
|
|
A14AA06
|
Quinbolone
|
|
|
|
|
A14AA07
|
Prasterone
|
|
|
|
|
A14AA08
|
Oxandrolone
|
|
|
|
|
A14AA09
|
Norethandrolone
|
|
|
|
A14AB
|
|
Estren derivatives
|
|
|
|
|
A14AB01
|
Nandrolone
|
|
|
|
|
A14AB02
|
Ethylestrenol
|
|
|
|
|
A14AB03
|
Oxabolone cipionate
|
|
|
A14B
|
|
|
Other anabolic agents
|
|
|
|
|
|
empty
|
|
A15
|
|
|
|
Appetite stimulants
|
|
|
|
|
|
empty
|
|
A16
|
|
|
|
Other alimentary tract and metabolism products
|
|
|
A16A
|
|
|
Other alimentary tract and metabolism products
|
|
|
|
A16AA
|
|
Amino acids and derivatives
|
|
|
|
|
A16AA01
|
Levocarnitine
|
|
|
|
|
A16AA02
|
Ademetionine
|
|
|
|
|
A16AA03
|
Levoglutamide
|
|
|
|
|
A16AA04
|
Mercaptamine
|
|
|
|
|
A16AA05
|
Carglumic acid
|
|
|
|
|
A16AA06
|
Betaine
|
|
|
|
A16AB
|
|
Enzymes
|
|
|
|
|
A16AB01
|
Alglucerase
|
|
|
|
|
A16AB02
|
Imiglucerase
|
|
|
|
|
A16AB03
|
Agalsidase alfa
|
|
|
|
|
A16AB04
|
Agalsidase beta
|
|
|
|
|
A16AB05
|
Laronidase
|
|
|
|
|
A16AB06
|
Sacrosidase
|
|
|
|
|
A16AB07
|
Alglucosidase alfa
|
|
|
|
|
A16AB08
|
Galsulfase
|
|
|
|
|
A16AB09
|
Idursulfase
|
|
|
|
|
A16AB10
|
Velaglucerase alfa
|
|
|
|
|
A16AB11
|
Taliglucerase alfa
|
|
|
|
A16AX
|
|
Various alimentary tract and metabolism products
|
|
|
|
|
A16AX01
|
Thioctic acid
|
|
|
|
|
A16AX02
|
Anethole trithione
|
|
|
|
|
A16AX03
|
Sodium phenylbutyrate
|
|
|
|
|
A16AX04
|
Nitisinone
|
|
|
|
|
A16AX05
|
Zinc acetate
|
|
|
|
|
A16AX06
|
Miglustat
|
|
|
|
|
A16AX07
|
Sapropterin
|
|
|
|
|
A16AX08
|
Teduglutide
|
|
|
|
|
A16AX09
|
Glycerol phenylbutyrate
|
B
|
|
|
|
|
Blood and blood forming organs
|
|
B01
|
|
|
|
Antithrombotic agents
|
|
|
B01A
|
|
|
Antithrombotic agents
|
|
|
|
B01AA
|
|
Vitamin K antagonists
|
|
|
|
|
B01AA01
|
Dicoumarol
|
|
|
|
|
B01AA02
|
Phenindione
|
|
|
|
|
B01AA03
|
Warfarin
|
|
|
|
|
B01AA04
|
Phenprocoumon
|
|
|
|
|
B01AA07
|
Acenocoumarol
|
|
|
|
|
B01AA08
|
Ethyl biscoumacetate
|
|
|
|
|
B01AA09
|
Clorindione
|
|
|
|
|
B01AA10
|
Diphenadione
|
|
|
|
|
B01AA11
|
Tioclomarol
|
|
|
|
|
B01AA12
|
Fluindione
|
|
|
|
B01AB
|
|
Heparin group
|
|
|
|
|
B01AB01
|
Heparin
|
|
|
|
|
B01AB02
|
Antithrombin III
|
|
|
|
|
B01AB04
|
Dalteparin
|
|
|
|
|
B01AB05
|
Enoxaparin
|
|
|
|
|
B01AB06
|
Nadroparin
|
|
|
|
|
B01AB07
|
Parnaparin
|
|
|
|
|
B01AB08
|
Reviparin
|
|
|
|
|
B01AB09
|
Danaparoid
|
|
|
|
|
B01AB10
|
Tinzaparin
|
|
|
|
|
B01AB11
|
Sulodexide
|
|
|
|
|
B01AB12
|
Bemiparin
|
|
|
|
|
B01AB51
|
Heparin, combinations
|
|
|
|
B01AC
|
|
Platelet aggregation inhibitors excluding heparin
|
|
|
|
|
B01AC01
|
Ditazole
|
|
|
|
|
B01AC02
|
Cloricromen
|
|
|
|
|
B01AC03
|
Picotamide
|
|
|
|
|
B01AC04
|
Clopidogrel
|
|
|
|
|
B01AC05
|
Ticlopidine
|
|
|
|
|
B01AC06
|
Acetylsalicylic acid
|
|
|
|
|
B01AC07
|
Dipyridamole
|
|
|
|
|
B01AC08
|
Carbasalate calcium
|
|
|
|
|
B01AC09
|
Epoprostenol
|
|
|
|
|
B01AC10
|
Indobufen
|
|
|
|
|
B01AC11
|
Iloprost
|
|
|
|
|
B01AC13
|
Abciximab
|
|
|
|
|
B01AC15
|
Aloxiprin
|
|
|
|
|
B01AC16
|
Eptifibatide
|
|
|
|
|
B01AC17
|
Tirofiban
|
|
|
|
|
B01AC18
|
Triflusal
|
|
|
|
|
B01AC19
|
Beraprost
|
|
|
|
|
B01AC21
|
Treprostinil
|
|
|
|
|
B01AC22
|
Prasugrel
|
|
|
|
|
B01AC23
|
Cilostazol
|
|
|
|
|
B01AC24
|
Ticagrelor
|
|
|
|
|
B01AC30
|
Combinations
|
|
|
|
|
B01AC56
|
Acetylsalicylic acid and esomeprazole
|
|
|
|
B01AD
|
|
Enzymes
|
|
|
|
|
B01AD01
|
Streptokinase
|
|
|
|
|
B01AD02
|
Alteplase
|
|
|
|
|
B01AD03
|
Anistreplase
|
|
|
|
|
B01AD04
|
Urokinase
|
|
|
|
|
B01AD05
|
Fibrinolysin
|
|
|
|
|
B01AD06
|
Brinase
|
|
|
|
|
B01AD07
|
Reteplase
|
|
|
|
|
B01AD08
|
Saruplase
|
|
|
|
|
B01AD09
|
Ancrod
|
|
|
|
|
B01AD10
|
Drotrecogin alfa (activated)
|
|
|
|
|
B01AD11
|
Tenecteplase
|
|
|
|
|
B01AD12
|
Protein C
|
|
|
|
B01AE
|
|
Direct thrombin inhibitors
|
|
|
|
|
B01AE01
|
Desirudin
|
|
|
|
|
B01AE02
|
Lepirudin
|
|
|
|
|
B01AE03
|
Argatroban
|
|
|
|
|
B01AE04
|
Melagatran
|
|
|
|
|
B01AE05
|
Ximelagatran
|
|
|
|
|
B01AE06
|
Bivalirudin
|
|
|
|
|
B01AE07
|
Dabigatran etexilate
|
|
|
|
B01AF
|
|
Direct factor Xa inhibitors
|
|
|
|
|
B01AF01
|
Rivaroxaban
|
|
|
|
|
B01AF02
|
Apixaban
|
|
|
|
B01AX
|
|
Other antithrombotic agents
|
|
|
|
|
B01AX01
|
Defibrotide
|
|
|
|
|
B01AX04
|
Dermatan sulfate
|
|
|
|
|
B01AX05
|
Fondaparinux
|
|
B02
|
|
|
|
Antihemorrhagics
|
|
|
B02A
|
|
|
Antifibrinolytics
|
|
|
|
B02AA
|
|
Amino acids
|
|
|
|
|
B02AA01
|
Aminocaproic acid
|
|
|
|
|
B02AA02
|
Tranexamic acid
|
|
|
|
|
B02AA03
|
Aminomethylbenzoic acid
|
|
|
|
B02AB
|
|
Proteinase inhibitors
|
|
|
|
|
B02AB01
|
Aprotinin
|
|
|
|
|
B02AB02
|
Alfa1 antitrypsin
|
|
|
|
|
B02AB04
|
Camostat
|
|
|
B02B
|
|
|
Vitamin K and other hemostatics
|
|
|
|
B02BA
|
|
Vitamin K
|
|
|
|
|
B02BA01
|
Phytomenadione
|
|
|
|
|
B02BA02
|
Menadione
|
|
|
|
B02BB
|
|
Fibrinogen
|
|
|
|
|
B02BB01
|
Human fibrinogen
|
|
|
|
B02BC
|
|
Local hemostatics
|
|
|
|
|
B02BC01
|
Absorbable gelatin sponge
|
|
|
|
|
B02BC02
|
Oxidized cellulose
|
|
|
|
|
B02BC03
|
Tetragalacturonic acid hydroxymethylester
|
|
|
|
|
B02BC05
|
Adrenalone
|
|
|
|
|
B02BC06
|
Thrombin
|
|
|
|
|
B02BC07
|
Collagen
|
|
|
|
|
B02BC08
|
Calcium alginate
|
|
|
|
|
B02BC09
|
Epinephrine
|
|
|
|
|
B02BC10
|
Fibrinogen, human
|
|
|
|
|
B02BC30
|
Combinations
|
|
|
|
B02BD
|
|
Blood coagulation factors
|
|
|
|
|
B02BD01
|
Coagulation factor IX, II, VII and X in combination (Prothrombin complex concentrate)
|
|
|
|
|
B02BD02
|
Coagulation factor VIII
|
|
|
|
|
B02BD03
|
Factor VIII inhibitor bypassing activity
|
|
|
|
|
B02BD04
|
Coagulation factor IX
|
|
|
|
|
B02BD05
|
Coagulation factor VII
|
|
|
|
|
B02BD06
|
Von Willebrand factor and coagulation factor VIII in combination
|
|
|
|
|
B02BD07
|
Coagulation factor XIII
|
|
|
|
|
B02BD08
|
Eptacog alfa (activated)
|
|
|
|
|
B02BD09
|
Nonacog alfa
|
|
|
|
|
B02BD10
|
von Willebrand factor
|
|
|
|
|
B02BD11
|
Catridecacog
|
|
|
|
|
B02BD12
|
Trenonacog alfa
|
|
|
|
|
B02BD30
|
Thrombin
|
|
|
|
B02BX
|
|
Other systemic hemostatics
|
|
|
|
|
B02BX01
|
Etamsylate
|
|
|
|
|
B02BX02
|
Carbazochrome
|
|
|
|
|
B02BX03
|
Batroxobin
|
|
|
|
|
B02BX04
|
Romiplostim
|
|
|
|
|
B02BX05
|
Eltrombopag
|
|
B03
|
|
|
|
Antianemic preparations
|
|
|
B03A
|
|
|
Iron preparations
|
|
|
|
B03AA
|
|
Iron bivalent, oral preparations
|
|
|
|
|
B03AA01
|
Ferrous glycine sulfate
|
|
|
|
|
B03AA02
|
Ferrous fumarate
|
|
|
|
|
B03AA03
|
Ferrous gluconate
|
|
|
|
|
B03AA04
|
Ferrous carbonate
|
|
|
|
|
B03AA05
|
Ferrous chloride
|
|
|
|
|
B03AA06
|
Ferrous succinate
|
|
|
|
|
B03AA07
|
Ferrous sulfate
|
|
|
|
|
B03AA08
|
Ferrous tartrate
|
|
|
|
|
B03AA09
|
Ferrous aspartate
|
|
|
|
|
B03AA10
|
Ferrous ascorbate
|
|
|
|
|
B03AA11
|
Ferrous iodine
|
|
|
|
B03AB
|
|
Iron trivalent, oral preparations
|
|
|
|
|
B03AB01
|
Ferric sodium citrate
|
|
|
|
|
B03AB02
|
Saccharated iron oxide
|
|
|
|
|
B03AB03
|
Sodium feredetate
|
|
|
|
|
B03AB04
|
Ferric hydroxide
|
|
|
|
|
B03AB05
|
Ferric oxide polymaltose complexes
|
|
|
|
|
B03AB06
|
Ferric citrate
|
|
|
|
|
B03AB07
|
Chondroitin sulfate-iron complex
|
|
|
|
|
B03AB08
|
Ferric acetyl transferrin
|
|
|
|
|
B03AB09
|
Ferric proteinsuccinylate
|
|
|
|
B03AC
|
|
Iron trivalent, parenteral preparations
|
|
|
|
|
B03AC01
|
Ferric oxide polymaltose complexes
|
|
|
|
|
B03AC02
|
Saccharated iron oxide
|
|
|
|
|
B03AC03
|
Iron-sorbitol-citric acid complex
|
|
|
|
|
B03AC05
|
Ferric sorbitol gluconic acid complex
|
|
|
|
|
B03AC06
|
Ferric oxide dextran complexes
|
|
|
|
|
B03AC07
|
Ferric sodium gluconate complex
|
|
|
|
B03AD
|
|
Iron in combination with folic acid
|
|
|
|
|
B03AD01
|
Ferrous amino acid complex
|
|
|
|
|
B03AD02
|
Ferrous fumarate
|
|
|
|
|
B03AD03
|
Ferrous sulfate
|
|
|
|
|
B03AD04
|
Ferric oxide polymaltose complexes
|
|
|
|
B03AE
|
|
Iron in other combinations
|
|
|
|
|
B03AE01
|
Iron, vitamin B12 and folic acid
|
|
|
|
|
B03AE02
|
Iron, multivitamins and folic acid
|
|
|
|
|
B03AE03
|
Iron and multivitamins
|
|
|
|
|
B03AE04
|
Iron, multivitamins and minerals
|
|
|
|
|
B03AE10
|
Various combinations
|
|
|
B03B
|
|
|
Vitamin B12 and folic acid
|
|
|
|
B03BA
|
|
Vitamin B12 (cyanocobalamin and analogues)
|
|
|
|
|
B03BA01
|
Cyanocobalamin
|
|
|
|
|
B03BA02
|
Cyanocobalamin tannin complex
|
|
|
|
|
B03BA03
|
Hydroxocobalamin
|
|
|
|
|
B03BA04
|
Cobamamide
|
|
|
|
|
B03BA05
|
Mecobalamin
|
|
|
|
|
B03BA51
|
Cyanocobalamin, combinations
|
|
|
|
|
B03BA53
|
Hydroxocobalamin, combinations
|
|
|
|
B03BB
|
|
Folic acid and derivatives
|
|
|
|
|
B03BB01
|
Folic acid
|
|
|
|
|
B03BB51
|
Folic acid, combinations
|
|
|
B03X
|
|
|
Other antianemic preparations
|
|
|
|
B03XA
|
|
Other antianemic preparations
|
|
|
|
|
B03XA01
|
Erythropoietin
|
|
|
|
|
B03XA02
|
Darbepoetin alfa
|
|
|
|
|
B03XA03
|
Methoxy polyethylene glycol-epoetin beta
|
|
|
|
|
B03XA04
|
Peginesatide
|
|
B05
|
|
|
|
Blood substitutes and perfusion solutions
|
|
|
B05A
|
|
|
Blood and related products
|
|
|
|
B05AA
|
|
Blood substitutes and plasma protein fractions
|
|
|
|
|
B05AA01
|
Serum albumin
|
|
|
|
|
B05AA02
|
Other plasma protein fractions
|
|
|
|
|
B05AA03
|
Fluorocarbon blood substitutes
|
|
|
|
|
B05AA05
|
Dextran
|
|
|
|
|
B05AA06
|
Gelatin agents
|
|
|
|
|
B05AA07
|
Hydroxyethylstarch
|
|
|
|
|
B05AA08
|
Hemoglobin crosfumaril
|
|
|
|
|
B05AA09
|
Hemoglobin raffimer
|
|
|
|
|
B05AA10
|
Hemoglobin glutamer (bovine)
|
|
|
|
B05AX
|
|
Other blood products
|
|
|
|
|
B05AX01
|
Erythrocytes
|
|
|
|
|
B05AX02
|
Thrombocytes
|
|
|
|
|
B05AX03
|
Blood plasma
|
|
|
|
|
B05AX04
|
Stem cells from umbilical cord blood
|
|
|
B05B
|
|
|
I.v. solutions
|
|
|
|
B05BA
|
|
Solutions for parenteral nutrition
|
|
|
|
|
B05BA01
|
Amino acids
|
|
|
|
|
B05BA02
|
Fat emulsions
|
|
|
|
|
B05BA03
|
Carbohydrates
|
|
|
|
|
B05BA04
|
Protein hydrolysates
|
|
|
|
|
B05BA10
|
Combinations
|
|
|
|
B05BB
|
|
Solutions affecting the electrolyte balance
|
|
|
|
|
B05BB01
|
Electrolytes
|
|
|
|
|
B05BB02
|
Electrolytes with carbohydrates
|
|
|
|
|
B05BB03
|
Trometamol
|
|
|
|
|
B05BB04
|
Electrolytes in combination with other drugs
|
|
|
|
B05BC
|
|
Solutions producing osmotic diuresis
|
|
|
|
|
B05BC01
|
Mannitol
|
|
|
|
|
B05BC02
|
Carbamide
|
|
|
B05C
|
|
|
Irrigating solutions
|
|
|
|
B05CA
|
|
Antiinfectives
|
|
|
|
|
B05CA01
|
Cetylpyridinium
|
|
|
|
|
B05CA02
|
Chlorhexidine
|
|
|
|
|
B05CA03
|
Nitrofural
|
|
|
|
|
B05CA04
|
Sulfamethizole
|
|
|
|
|
B05CA05
|
Taurolidine
|
|
|
|
|
B05CA06
|
Mandelic acid
|
|
|
|
|
B05CA07
|
Noxytiolin
|
|
|
|
|
B05CA08
|
Ethacridine lactate
|
|
|
|
|
B05CA09
|
Neomycin
|
|
|
|
|
B05CA10
|
Combinations
|
|
|
|
B05CB
|
|
Salt solutions
|
|
|
|
|
B05CB01
|
Sodium chloride
|
|
|
|
|
B05CB02
|
Sodium citrate
|
|
|
|
|
B05CB03
|
Magnesium citrate
|
|
|
|
|
B05CB04
|
Sodium bicarbonate
|
|
|
|
|
B05CB10
|
Combinations
|
|
|
|
B05CX
|
|
Other irrigating solutions
|
|
|
|
|
B05CX01
|
Glucose
|
|
|
|
|
B05CX02
|
Sorbitol
|
|
|
|
|
B05CX03
|
Glycine
|
|
|
|
|
B05CX04
|
Mannitol
|
|
|
|
|
B05CX10
|
Combinations
|
|
|
B05D
|
|
|
Peritoneal dialytics
|
|
|
|
B05DA
|
|
Isotonic solutions
|
|
|
|
|
|
empty
|
|
|
|
B05DB
|
|
Hypertonic solutions
|
|
|
|
|
|
empty
|
|
|
B05X
|
|
|
I.v. solution additives
|
|
|
|
B05XA
|
|
Electrolyte solutions
|
|
|
|
|
B05XA01
|
Potassium chloride
|
|
|
|
|
B05XA02
|
Sodium bicarbonate
|
|
|
|
|
B05XA03
|
Sodium chloride
|
|
|
|
|
B05XA04
|
Ammonium chloride
|
|
|
|
|
B05XA05
|
Magnesium sulfate
|
|
|
|
|
B05XA06
|
Potassium phosphate, including combinations with other potassium salts
|
|
|
|
|
B05XA07
|
Calcium chloride
|
|
|
|
|
B05XA08
|
Sodium acetate
|
|
|
|
|
B05XA09
|
Sodium phosphate
|
|
|
|
|
B05XA10
|
Magnesium phosphate
|
|
|
|
|
B05XA11
|
Magnesium chloride
|
|
|
|
|
B05XA12
|
Zinc chloride
|
|
|
|
|
B05XA13
|
Hydrochloric acid
|
|
|
|
|
B05XA14
|
Sodium glycerophosphate
|
|
|
|
|
B05XA15
|
Potassium lactate
|
|
|
|
|
B05XA16
|
Cardioplegia solutions
|
|
|
|
|
B05XA17
|
Potassium acetate
|
|
|
|
|
B05XA30
|
Combinations of electrolytes
|
|
|
|
|
B05XA31
|
Electrolytes in combination with other drugs
|
|
|
|
B05XB
|
|
Amino acids
|
|
|
|
|
B05XB01
|
Arginine hydrochloride
|
|
|
|
|
B05XB02
|
Alanyl glutamine
|
|
|
|
|
B05XB03
|
Lysine
|
|
|
|
B05XC
|
|
Vitamins
|
|
|
|
|
|
empty
|
|
|
|
B05XX
|
|
Other i.v. solution additives
|
|
|
|
|
B05XX02
|
Trometamol
|
|
|
B05Z
|
|
|
Hemodialytics and hemofiltrates
|
|
|
|
B05ZA
|
|
Hemodialytics, concentrates
|
|
|
|
|
|
empty
|
|
|
|
B05ZB
|
|
Hemofiltrates
|
|
|
|
|
|
empty
|
|
B06
|
|
|
|
Other hematological agents
|
|
|
B06A
|
|
|
Other hematological agents
|
|
|
|
B06AA
|
|
Enzymes
|
|
|
|
|
B06AA02
|
Fibrinolysin and desoxyribonuclease
|
|
|
|
|
B06AA03
|
Hyaluronidase
|
|
|
|
|
B06AA04
|
Chymotrypsin
|
|
|
|
|
B06AA07
|
Trypsin
|
|
|
|
|
B06AA10
|
Desoxyribonuclease
|
|
|
|
|
B06AA11
|
Bromelain
|
|
|
|
|
B06AA55
|
Streptokinase, combinations
|
|
|
|
B06AB
|
|
Other hematological products
|
|
|
|
|
B06AB01
|
Hematin
|
|
|
|
B06AC
|
|
Drugs used in hereditary angioedema
|
|
|
|
|
B06AC01
|
C1-inhibitor, plasma derived
|
|
|
|
|
B06AC02
|
Icatibant
|
|
|
|
|
B06AC03
|
Ecallantide
|
|
|
|
|
B06AC04
|
Conestat alfa
|
C
|
|
|
|
|
Cardiovascular system
|
|
C01
|
|
|
|
Cardiac therapy
|
|
|
C01A
|
|
|
Cardiac glycosides
|
|
|
|
C01AA
|
|
Digitalis glycosides
|
|
|
|
|
C01AA01
|
Acetyldigitoxin
|
|
|
|
|
C01AA02
|
Acetyldigoxin
|
|
|
|
|
C01AA03
|
Digitalis leaves
|
|
|
|
|
C01AA04
|
Digitoxin
|
|
|
|
|
C01AA05
|
Digoxin
|
|
|
|
|
C01AA06
|
Lanatoside C
|
|
|
|
|
C01AA07
|
Deslanoside
|
|
|
|
|
C01AA08
|
Metildigoxin
|
|
|
|
|
C01AA09
|
Gitoformate
|
|
|
|
|
C01AA52
|
Acetyldigoxin, combinations
|
|
|
|
C01AB
|
|
Scilla glycosides
|
|
|
|
|
C01AB01
|
Proscillaridin
|
|
|
|
|
C01AB51
|
Proscillaridin, combinations
|
|
|
|
C01AC
|
|
Strophantus glycosides
|
|
|
|
|
C01AC01
|
G-strophanthin
|
|
|
|
|
C01AC03
|
Cymarin
|
|
|
|
C01AX
|
|
Other cardiac glycosides
|
|
|
|
|
C01AX02
|
Peruvoside
|
|
|
C01B
|
|
|
Antiarrhythmics, class I and III
|
|
|
|
C01BA
|
|
Antiarrhythmics, class Ia
|
|
|
|
|
C01BA01
|
Quinidine
|
|
|
|
|
C01BA02
|
Procainamide
|
|
|
|
|
C01BA03
|
Disopyramide
|
|
|
|
|
C01BA04
|
Sparteine
|
|
|
|
|
C01BA05
|
Ajmaline
|
|
|
|
|
C01BA08
|
Prajmaline
|
|
|
|
|
C01BA12
|
Lorajmine
|
|
|
|
|
C01BA51
|
Quinidine, combinations excluding psycholeptics
|
|
|
|
|
C01BA71
|
Quinidine, combinations with psycholeptics
|
|
|
|
C01BB
|
|
Antiarrhythmics, class Ib
|
|
|
|
|
C01BB01
|
Lidocaine
|
|
|
|
|
C01BB02
|
Mexiletine
|
|
|
|
|
C01BB03
|
Tocainide
|
|
|
|
|
C01BB04
|
Aprindine
|
|
|
|
C01BC
|
|
Antiarrhythmics, class Ic
|
|
|
|
|
C01BC03
|
Propafenone
|
|
|
|
|
C01BC04
|
Flecainide
|
|
|
|
|
C01BC07
|
Lorcainide
|
|
|
|
|
C01BC08
|
Encainide
|
|
|
|
|
C01BC09
|
Ethacizine
עריכה
|
|
|
|
C01BD
|
|
Antiarrhythmics, class III
|
|
|
|
|
C01BD01
|
Amiodarone
|
|
|
|
|
C01BD02
|
Bretylium tosilate
|
|
|
|
|
C01BD03
|
Bunaftine
|
|
|
|
|
C01BD04
|
Dofetilide
|
|
|
|
|
C01BD05
|
Ibutilide
|
|
|
|
|
C01BD06
|
Tedisamil
|
|
|
|
|
C01BD07
|
Dronedarone
|
|
|
|
C01BG
|
|
Other antiarrhythmics, class I and III
|
|
|
|
|
C01BG01
|
Moracizine
|
|
|
|
|
C01BG07
|
Cibenzoline
|
|
|
|
|
C01BG11
|
Vernakalant
|
|
|
C01C
|
|
|
Cardiac stimulants excluding cardiac glycosides
|
|
|
|
C01CA
|
|
Adrenergic and dopaminergic agents
|
|
|
|
|
C01CA01
|
Etilefrine
C01CA02
Isoprenaline
C01CA03
Norepinephrine
C01CA04
Dopamine
C01CA05
Norfenefrine
C01CA06
Phenylephrine
C01CA07
Dobutamine
C01CA08
Oxedrine
C01CA09
Metaraminol
C01CA10
Methoxamine
C01CA11
Mephentermine
C01CA12
Dimetofrine
C01CA13
Prenalterol
C01CA14
Dopexamine
C01CA15
Gepefrine
C01CA16
Ibopamine
C01CA17
Midodrine
C01CA18
Octopamine
C01CA19
Fenoldopam
C01CA21
Cafedrine
C01CA22
Arbutamine
C01CA23
Theodrenaline
C01CA24
Epinephrine
C01CA25
Amezinium metilsulfate
C01CA26
Ephedrine
C01CA30
Combinations
C01CA51
Etilefrine, combinations
|
|
|
|
C01CE
|
|
Phosphodiesterase inhibitors
|
|
|
|
C01CX
|
|
Other cardiac stimulants
|
|
|
C01D
|
|
|
Vasodilators used in cardiac diseases
|
|
|
|
C01DA
|
|
Organic nitrates
|
|
|
|
C01DB
|
|
Quinolone vasodilators
|
|
|
|
C01DX
|
|
Other vasodilators used in cardiac diseases
|
|
|
C01E
|
|
|
Other cardiac preparations
|
|
|
|
C01EA
|
|
Prostaglandins
|
|
|
|
C01EB
|
|
Other cardiac preparations
|
|
|
|
C01EX
|
|
Other cardiac combination products
|
|
|
|
|
|
empty
|
|
C02
|
|
|
|
Antihypertensives
|
|
|
|
|
|
להשלים
|
|
C03
|
|
|
|
Diuretics
|
|
|
|
|
|
להשלים
|
|
C04
|
|
|
|
Peripheral vasodilators
|
|
|
C04A
|
|
|
Peripheral vasodilators
|
|
|
|
C04AA
|
|
2-amino-1-phenylethanol derivatives
|
|
|
|
|
C04AA01
|
Isoxsuprine
|
|
|
|
|
C04AA02
|
Buphenine
|
|
|
|
|
C04AA31
|
Bamethan
|
|
|
|
C04AB
|
|
Imidazoline derivatives
|
|
|
|
|
C04AB01
|
Phentolamine
|
|
|
|
|
C04AB02
|
Tolazoline
|
|
|
|
C04AC
|
|
Nicotinic acid and derivatives
|
|
|
|
|
C04AC01
|
Nicotinic acid
|
|
|
|
|
C04AC02
|
Nicotinyl alcohol (pyridylcarbinol)
|
|
|
|
|
C04AC03
|
Inositol nicotinate
|
|
|
|
|
C04AC07
|
Ciclonicate
|
|
|
|
C04AD
|
|
Purine derivatives
|
|
|
|
|
C04AD01
|
Pentifylline
|
|
|
|
|
C04AD02
|
Xantinol nicotinate
|
|
|
|
|
C04AD03
|
Pentoxifylline
|
|
|
|
|
C04AD04
|
Etofylline nicotinate
|
|
|
|
C04AE
|
|
Ergot alkaloids
|
|
|
|
|
C04AE01
|
Ergoloid mesylates
|
|
|
|
|
C04AE02
|
Nicergoline
|
|
|
|
|
C04AE04
|
Dihydroergocristine
|
|
|
|
|
C04AE51
|
Ergoloid mesylates, combinations
|
|
|
|
|
C04AE54
|
Dihydroergocristine, combinations
|
|
|
|
C04AF
|
|
Enzymes
|
|
|
|
|
C04AF01
|
Kallidinogenase
|
|
|
|
C04AX
|
|
Other peripheral vasodilators
|
|
|
|
|
C04AX01
|
Cyclandelate
|
|
|
|
|
C04AX02
|
Phenoxybenzamine
|
|
|
|
|
C04AX07
|
Vincamine
|
|
|
|
|
C04AX10
|
Moxisylyte
|
|
|
|
|
C04AX11
|
Bencyclane
|
|
|
|
|
C04AX17
|
Vinburnine
|
|
|
|
|
C04AX19
|
Sulcotidil
|
|
|
|
|
C04AX20
|
Buflomedil
|
|
|
|
|
C04AX21
|
Naftidrofuryl
|
|
|
|
|
C04AX23
|
Butalamine
|
|
|
|
|
C04AX24
|
Visnadine
|
|
|
|
|
C04AX26
|
Cetiedil
|
|
|
|
|
C04AX27
|
Cinepazide
|
|
|
|
|
C04AX28
|
Ifenprodil
|
|
|
|
|
C04AX30
|
Azapetine
|
|
|
|
|
C04AX32
|
Fasudil
|
|
C05
|
|
|
|
Vasoprotectives
|
|
C07
|
|
|
|
Beta blocking agents
|
|
C08
|
|
|
|
Calcium channel blockers
|
|
C09
|
|
|
|
Agents acting on the renin-angiotensin system
|
|
C10
|
|
|
|
Lipid modifying agents
|
|
|
C10A
|
|
|
Lipid modifying agents, plain
|
|
|
|
C10AA
|
|
HMG CoA reductase inhibitors
|
|
|
|
C10AB
|
|
Fibrates
|
|
|
|
C10AC
|
|
Bile acid sequestrants
|
|
|
|
|
C10AC01
|
Colestyramine
|
|
|
|
|
C10AC02
|
Colestipol
|
|
|
|
|
C10AC03
|
Colextran
|
|
|
|
|
C10AC04
|
Colesevelam
|
|
|
|
C10AD
|
|
Nicotinic acid and derivatives
|
|
|
|
C10AX
|
|
Other lipid modifying agents
|
|
|
C10B
|
|
|
Lipid modifying agents, combinations
|
D
|
|
|
|
|
Dermatologicals
|
|
D01
|
|
|
|
Antifungals for dermatological use
|
|
D02
|
|
|
|
Emollients and protectives
|
|
D03
|
|
|
|
Preparations for treatment of wounds and ulcers
|
|
D04
|
|
|
|
Antipruritics, including antihistamines, anesthetics, etc
|
|
D05
|
|
|
|
Antipsoriatics
|
|
D06
|
|
|
|
Antibiotics and chemotherapeutics for dermatological use
|
|
D07
|
|
|
|
Corticosteroids, dermatological preparations
|
|
D08
|
|
|
|
Antiseptics and disinfectants
|
|
D09
|
|
|
|
Medicated dressings
|
|
D10
|
|
|
|
Anti-acne preparations
|
|
D11
|
|
|
|
Other dermatological preparations
|
G
|
|
|
|
|
Genito-urinary system and sex hormones
|
|
G01
|
|
|
|
Gynecological antiinfectives and antiseptics
|
|
G02
|
|
|
|
Other gynecologicals
|
|
G03
|
|
|
|
Sex hormones and modulators of the genital system
|
|
G04
|
|
|
|
Urologicals
|
|
|
G04B
|
|
|
Urologicals
|
|
|
|
G04BA
|
|
Acidifiers
|
|
|
|
G04BC
|
|
Urinary concrement solvents
|
|
|
|
G04BD
|
|
Drugs for urinary frequency and incontinence
|
|
|
|
|
G04BD01
|
Emepronium
|
|
|
|
|
G04BD02
|
Flavoxate
|
|
|
|
|
G04BD03
|
Meladrazine
|
|
|
|
|
G04BD04
|
Oxybutynin
|
|
|
|
|
G04BD05
|
Terodiline
|
|
|
|
|
G04BD06
|
Propiverine
|
|
|
|
|
G04BD07
|
Tolterodine
|
|
|
|
|
G04BD08
|
Solifenacin
|
|
|
|
|
G04BD09
|
Trospium
|
|
|
|
|
G04BD10
|
Darifenacin
|
|
|
|
|
G04BD11
|
Fesoterodine
|
|
|
|
|
G04BD12
|
Mirabegron
|
|
|
|
G04BE
|
|
Drugs used in erectile dysfunction
|
|
|
|
|
G04BE01
|
Alprostadil
|
|
|
|
|
G04BE02
|
Papaverine
|
|
|
|
|
G04BE03
|
Sildenafil
|
|
|
|
|
G04BE04
|
Yohimbin
|
|
|
|
|
G04BE06
|
Moxisylyte
|
|
|
|
|
G04BE07
|
Apomorphine
|
|
|
|
|
G04BE08
|
Tadalafil
|
|
|
|
|
G04BE09
|
Vardenafil
|
|
|
|
|
G04BE30
|
Combinations
|
|
|
|
|
G04BE52
|
Papaverine, combinations
|
|
|
|
G04BX
|
|
Other urologicals
|
|
|
|
|
|
להשלים
|
|
|
G04C
|
|
|
Drugs used in benign prostatic hypertrophy
|
|
|
|
G04CA
|
|
Alpha-adrenoreceptor antagonists
|
|
|
|
G04CB
|
|
Testosterone-5-alpha reductase inhibitors
|
|
|
|
G04CX
|
|
Other drugs used in benign prostatic hypertrophy
|
H
|
|
|
|
|
Systemic hormonal preparations, excluding sex hormones and insulins
|
|
H01
|
|
|
|
Pituitary and hypothalamic hormones and analogues
|
|
H02
|
|
|
|
Corticosteroids for systemic use
|
|
H03
|
|
|
|
Thyroid therapy
|
|
H04
|
|
|
|
Pancreatic hormones
|
|
H05
|
|
|
|
Calcium homeostasis
|
J
|
|
|
|
|
Antiinfectives for systemic use
|
|
J01
|
|
|
|
Antibacterials for systemic use
|
|
|
J01A
|
|
|
Tetracyclines
|
|
|
J01B
|
|
|
Amphenicols
|
|
|
J01C
|
|
|
Beta-lactam antibacterials, penicillins
|
|
|
J01D
|
|
|
Other beta-lactam antibacterials
|
|
|
J01E
|
|
|
Sulfonamides and trimethoprim
|
|
|
J01F
|
|
|
Macrolides, lincosamides and streptogramins
|
|
|
J01G
|
|
|
Aminoglycoside antibacterials
|
|
|
J01M
|
|
|
Quinolone antibacterials
|
|
|
J01R
|
|
|
Combinations of antibacterials
|
|
|
J01X
|
|
|
Other antibacterials
|
|
|
|
J01XA
|
|
Glycopeptide antibacterials
|
|
|
|
J01XB
|
|
Polymyxins
|
|
|
|
J01XC
|
|
Steroid antibacterials
|
|
|
|
J01XD
|
|
Imidazole derivatives
|
|
|
|
J01XE
|
|
Nitrofuran derivatives
|
|
|
|
J01XX
|
|
Other antibacterials
|
|
J02
|
|
|
|
Antimycotics for systemic use
|
|
J04
|
|
|
|
Antimycobacterials
|
|
J05
|
|
|
|
Antivirals for systemic use
|
|
|
J05A
|
|
|
Direct acting antiviral drugs
|
|
|
|
J05AA
|
|
Thiosemicarbazones
|
|
|
|
J05AB
|
|
Nucleosides and nucleotides excluding reverse transcriptase inhibitors
|
|
|
|
J05AC
|
|
Cyclic amines
|
|
|
|
J05AD
|
|
Phosphonic acid derivatives
|
|
|
|
J05AE
|
|
Protease inhibitors
|
|
|
|
J05AF
|
|
Nucleoside and nucleotide reverse transcriptase inhibitors
|
|
|
|
|
J05AF01
|
Zidovudine
|
|
|
|
|
J05AF02
|
Didanosine
|
|
|
|
|
J05AF03
|
Zalcitabine
|
|
|
|
|
J05AF04
|
Stavudine
|
|
|
|
|
J05AF05
|
Lamivudine
|
|
|
|
|
J05AF06
|
Abacavir
|
|
|
|
|
J05AF07
|
Tenofovir disoproxil
|
|
|
|
|
J05AF08
|
Adefovir dipivoxil
|
|
|
|
|
J05AF09
|
Emtricitabine
|
|
|
|
|
J05AF10
|
Entecavir
|
|
|
|
|
J05AF11
|
Telbivudine
|
|
|
|
|
J05AF12
|
Clevudine
|
|
|
|
J05AG
|
|
Non-nucleoside reverse transcriptase inhibitors
|
|
|
|
|
J05AG01
|
Nevirapine
|
|
|
|
|
J05AG02
|
Delavirdine
|
|
|
|
|
J05AG03
|
Efavirenz
|
|
|
|
|
J05AG04
|
Etravirine
|
|
|
|
|
J05AG05
|
Rilpivirine
|
|
|
|
J05AH
|
|
Neuraminidase inhibitors
|
|
|
|
|
J05AH01
|
Zanamivir
|
|
|
|
|
J05AH02
|
Oseltamivir
|
|
|
|
J05AR
|
|
Antivirals for treatment of HIV infections, combinations
|
|
|
|
|
J05AR01
|
Zidovudine and lamivudine
|
|
|
|
|
J05AR02
|
Lamivudine and abacavir
|
|
|
|
|
J05AR03
|
Tenofovir disoproxil and emtricitabine
|
|
|
|
|
J05AR04
|
Zidovudine, lamivudine and abacavir
|
|
|
|
|
J05AR05
|
Zidovudine, lamivudine and nevirapine
|
|
|
|
|
J05AR06
|
Emtricitabine, tenofovir disoproxil and efavirenz
|
|
|
|
|
J05AR07
|
Stavudine, lamivudine and nevirapine
|
|
|
|
|
J05AR08
|
Emtricitabine, tenofovir disoproxil and rilpivirine
|
|
|
|
|
J05AR09
|
Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat
|
|
|
|
|
J05AR10
|
Lopinavir and ritonavir
|
|
|
|
J05AX
|
|
Other antivirals
|
|
|
|
|
J05AX01
|
Moroxydine
|
|
|
|
|
J05AX02
|
Lysozyme
|
|
|
|
|
J05AX05
|
Inosine pranobex
|
|
|
|
|
J05AX06
|
Pleconaril
|
|
|
|
|
J05AX07
|
Enfuvirtide
|
|
|
|
|
J05AX08
|
Raltegravir
|
|
|
|
|
J05AX09
|
Maraviroc
|
|
|
|
|
J05AX10
|
Maribavir
|
|
|
|
|
J05AX11
|
Elvitegravir
|
|
J06
|
|
|
|
Immune sera and immunoglobulins
|
|
|
J06A
|
|
|
Immune sera
|
|
|
|
J06AA
|
|
Immune sera
|
|
|
|
|
J06AA01
|
Diphtheria antitoxin
|
|
|
|
|
J06AA02
|
Tetanus antitoxin
|
|
|
|
|
J06AA03
|
Snake venom antiserum
|
|
|
|
|
J06AA04
|
Botulinum antitoxin
|
|
|
|
|
J06AA05
|
Gas-gangrene sera
|
|
|
|
|
J06AA06
|
Rabies serum
|
|
|
J06B
|
|
|
Immunoglobulins
|
|
|
|
J06BA
|
|
Immunoglobulins, normal human
|
|
|
|
|
J06BA01
|
Immunoglobulins, normal human, for extravascular administration
|
|
|
|
|
J06BA02
|
Immunoglobulins, normal human, for intravascular administration
|
|
|
|
J06BB
|
|
Specific immunoglobulins
|
|
|
|
|
J06BB01
|
Anti-D (rh) immunoglobulin
|
|
|
|
|
J06BB02
|
Tetanus immunoglobulin
|
|
|
|
|
J06BB03
|
Varicella/zoster immunoglobulin
|
|
|
|
|
J06BB04
|
Hepatitis B immunoglobulin
|
|
|
|
|
J06BB05
|
Rabies immunoglobulin
|
|
|
|
|
J06BB06
|
Rubella immunoglobulin
|
|
|
|
|
J06BB07
|
Vaccinia immunoglobulin
|
|
|
|
|
J06BB08
|
Staphylococcus immunoglobulin
|
|
|
|
|
J06BB09
|
Cytomegalovirus immunoglobulin
|
|
|
|
|
J06BB10
|
Diphtheria immunoglobulin
|
|
|
|
|
J06BB11
|
Hepatitis A immunoglobulin
|
|
|
|
|
J06BB12
|
Encephalitis, tick borne immunoglobulin
|
|
|
|
|
J06BB13
|
Pertussis immunoglobulin
|
|
|
|
|
J06BB14
|
Morbilli immunoglobulin
|
|
|
|
|
J06BB15
|
Parotitis immunoglobulin
|
|
|
|
|
J06BB16
|
Palivizumab
|
|
|
|
|
J06BB17
|
Motavizumab
|
|
|
|
|
J06BB30
|
Combinations
|
|
|
|
J06BC
|
|
Other immunoglobulins
|
|
|
|
|
J06BC01
|
Nebacumab
|
L
|
|
|
|
|
Antineoplastic and immunomodulating agents
|
|
L01
|
|
|
|
Antineoplastic agents
|
|
|
L01A
|
|
|
Alkylating agents
|
|
|
|
L01AA
|
|
Nitrogen mustard analogues
|
|
|
|
|
L01AA01
|
Cyclophosphamide
|
|
|
|
|
L01AA02
|
Chlorambucil
|
|
|
|
|
L01AA03
|
Melphalan
|
|
|
|
|
L01AA05
|
Chlormethine
|
|
|
|
|
L01AA06
|
Ifosfamide
|
|
|
|
|
L01AA07
|
Trofosfamide
|
|
|
|
|
L01AA08
|
Prednimustine
|
|
|
|
|
L01AA09
|
Bendamustine
|
|
|
|
L01AB
|
|
Alkyl sulfonates
|
|
|
|
|
L01AB01
|
Busulfan
|
|
|
|
|
L01AB02
|
Treosulfan
|
|
|
|
|
L01AB03
|
Mannosulfan
|
|
|
|
L01AC
|
|
Ethylene imines
|
|
|
|
|
L01AC01
|
Thiotepa
|
|
|
|
|
L01AC02
|
Triaziquone
|
|
|
|
|
L01AC03
|
Carboquone
|
|
|
|
L01AD
|
|
Nitrosoureas
|
|
|
|
|
L01AD01
|
Carmustine
|
|
|
|
|
L01AD02
|
Lomustine
|
|
|
|
|
L01AD03
|
Semustine
|
|
|
|
|
L01AD04
|
Streptozocin
|
|
|
|
|
L01AD05
|
Fotemustine
|
|
|
|
|
L01AD06
|
Nimustine
|
|
|
|
|
L01AD07
|
Ranimustine
|
|
|
|
L01AG
|
|
Epoxides
|
|
|
|
|
L01AG01
|
Etoglucid
|
|
|
|
L01AX
|
|
Other alkylating agents
|
|
|
|
|
L01AX01
|
Mitobronitol
|
|
|
|
|
L01AX02
|
Pipobroman
|
|
|
|
|
L01AX03
|
Temozolomide
|
|
|
|
|
L01AX04
|
Dacarbazine
|
|
|
L01B
|
|
|
Antimetabolites
|
|
|
|
L01BA
|
|
Folic acid analogues
|
|
|
|
|
L01BA01
|
Methotrexate
|
|
|
|
|
L01BA03
|
Raltitrexed
|
|
|
|
|
L01BA04
|
Pemetrexed
|
|
|
|
|
L01BA05
|
Pralatrexate
|
|
|
|
L01BB
|
|
Purine analogues
|
|
|
|
|
L01BB02
|
Mercaptopurine
|
|
|
|
|
L01BB03
|
Tioguanine
|
|
|
|
|
L01BB04
|
Cladribine
|
|
|
|
|
L01BB05
|
Fludarabine
|
|
|
|
|
L01BB06
|
Clofarabine
|
|
|
|
|
L01BB07
|
Nelarabine
|
|
|
|
L01BC
|
|
Pyrimidine analogues
|
|
|
|
|
L01BC01
|
Cytarabine
|
|
|
|
|
L01BC02
|
Fluorouracil
|
|
|
|
|
L01BC03
|
Tegafur
|
|
|
|
|
L01BC04
|
Carmofur
|
|
|
|
|
L01BC05
|
Gemcitabine
|
|
|
|
|
L01BC06
|
Capecitabine
|
|
|
|
|
L01BC07
|
Azacitidine
|
|
|
|
|
L01BC08
|
Decitabine
|
|
|
|
|
L01BC52
|
Fluorouracil, combinations
|
|
|
|
|
L01BC53
|
Tegafur, combinations
|
|
|
L01C
|
|
|
Plant alkaloids and other natural products
|
|
|
|
L01CA
|
|
Vinca alkaloids and analogues
|
|
|
|
|
L01CA01
|
Vinblastine
|
|
|
|
|
L01CA02
|
Vincristine
|
|
|
|
|
L01CA03
|
Vindesine
|
|
|
|
|
L01CA04
|
Vinorelbine
|
|
|
|
|
L01CA05
|
Vinflunine
|
|
|
|
L01CB
|
|
Podophyllotoxin derivatives
|
|
|
|
|
L01CB01
|
Etoposide
|
|
|
|
|
L01CB02
|
Teniposide
|
|
|
|
L01CC
|
|
Colchicine derivatives
|
|
|
|
|
L01CC01
|
Demecolcine
|
|
|
|
L01CD
|
|
Taxanes
|
|
|
|
|
L01CD01
|
Paclitaxel
|
|
|
|
|
L01CD02
|
Docetaxel
|
|
|
|
|
L01CD03
|
Paclitaxel poliglumex
|
|
|
|
|
L01CD04
|
Cabazitaxel
|
|
|
|
L01CX
|
|
Other plant alkaloids and natural products
|
|
|
|
|
L01CX01
|
Trabectedin
|
|
|
L01D
|
|
|
Cytotoxic antibiotics and related substances
|
|
|
|
L01DA
|
|
Actinomycines
|
|
|
|
|
L01DA01
|
Dactinomycin
|
|
|
|
L01DB
|
|
Anthracyclines and related substances
|
|
|
|
|
L01DB01
|
Doxorubicin
|
|
|
|
|
L01DB02
|
Daunorubicin
|
|
|
|
|
L01DB03
|
Epirubicin
|
|
|
|
|
L01DB04
|
Aclarubicin
|
|
|
|
|
L01DB05
|
Zorubicin
|
|
|
|
|
L01DB06
|
Idarubicin
|
|
|
|
|
L01DB07
|
Mitoxantrone
|
|
|
|
|
L01DB08
|
Pirarubicin
|
|
|
|
|
L01DB09
|
Valrubicin
|
|
|
|
|
L01DB10
|
Amrubicin
|
|
|
|
|
L01DB11
|
Pixantrone
|
|
|
|
L01DC
|
|
Other cytotoxic antibiotics
|
|
|
|
|
L01DC01
|
Bleomycin
|
|
|
|
|
L01DC02
|
Plicamycin
|
|
|
|
|
L01DC03
|
Mitomycin
|
|
|
|
|
L01DC04
|
Ixabepilone
|
|
|
L01X
|
|
|
Other antineoplastic agents
|
|
|
|
L01XA
|
|
Platinum compounds
|
|
|
|
|
L01XA01
|
Cisplatin
|
|
|
|
|
L01XA02
|
Carboplatin
|
|
|
|
|
L01XA03
|
Oxaliplatin
|
|
|
|
|
L01XA04
|
Satraplatin
|
|
|
|
|
L01XA05
|
Polyplatillen
|
|
|
|
L01XB
|
|
Methylhydrazines
|
|
|
|
|
L01XB01
|
Procarbazine
|
|
|
|
L01XC
|
|
Monoclonal antibodies
|
|
|
|
|
L01XC01
|
Edrecolomab
|
|
|
|
|
L01XC02
|
Rituximab
|
|
|
|
|
L01XC03
|
Trastuzumab
|
|
|
|
|
L01XC04
|
Alemtuzumab
|
|
|
|
|
L01XC05
|
Gemtuzumab
|
|
|
|
|
L01XC06
|
Cetuximab
|
|
|
|
|
L01XC07
|
Bevacizumab
|
|
|
|
|
L01XC08
|
Panitumumab
|
|
|
|
|
L01XC09
|
Catumaxomab
|
|
|
|
|
L01XC10
|
Ofatumumab
|
|
|
|
|
L01XC11
|
Ipilimumab
|
|
|
|
|
L01XC12
|
Brentuximab vedotin
|
|
|
|
|
L01XC13
|
Pertuzumab
|
|
|
|
L01XD
|
|
Sensitizers used in photodynamic/radiation therapy
|
|
|
|
|
L01XD01
|
Porfimer sodium
|
|
|
|
|
L01XD03
|
Methyl aminolevulinate
|
|
|
|
|
L01XD04
|
Aminolevulinic acid
|
|
|
|
|
L01XD05
|
Temoporfin
|
|
|
|
|
L01XD06
|
Efaproxiral
|
|
|
|
L01XE
|
|
Protein kinase inhibitors
|
|
|
|
|
L01XE01
|
Imatinib
|
|
|
|
|
L01XE02
|
Gefitinib
|
|
|
|
|
L01XE03
|
Erlotinib
|
|
|
|
|
L01XE04
|
Sunitinib
|
|
|
|
|
L01XE05
|
Sorafenib
|
|
|
|
|
L01XE06
|
Dasatinib
|
|
|
|
|
L01XE07
|
Lapatinib
|
|
|
|
|
L01XE08
|
Nilotinib
|
|
|
|
|
L01XE09
|
Temsirolimus
|
|
|
|
|
L01XE10
|
Everolimus
|
|
|
|
|
L01XE11
|
Pazopanib
|
|
|
|
|
L01XE12
|
Vandetanib
|
|
|
|
|
L01XE13
|
Afatinib
|
|
|
|
|
L01XE14
|
Bosutinib
|
|
|
|
|
L01XE15
|
Vemurafenib
|
|
|
|
|
L01XE16
|
Crizotinib
|
|
|
|
|
L01XE17
|
Axitinib
|
|
|
|
|
L01XE18
|
Ruxolitinib
|
|
|
|
|
L01XE19
|
Ridaforolimus
|
|
|
|
|
L01XE21
|
Regorafenib
|
|
|
|
|
L01XE22
|
Masitinib
|
|
|
|
L01XX
|
|
Other antineoplastic agents
|
|
|
|
|
L01XX01
|
Amsacrine
|
|
|
|
|
L01XX02
|
Asparaginase
|
|
|
|
|
L01XX03
|
Altretamine
|
|
|
|
|
L01XX05
|
Hydroxycarbamide
|
|
|
|
|
L01XX07
|
Lonidamine
|
|
|
|
|
L01XX08
|
Pentostatin
|
|
|
|
|
L01XX09
|
Miltefosine
|
|
|
|
|
L01XX10
|
Masoprocol
|
|
|
|
|
L01XX11
|
Estramustine
|
|
|
|
|
L01XX14
|
Tretinoin
|
|
|
|
|
L01XX16
|
Mitoguazone
|
|
|
|
|
L01XX17
|
Topotecan
|
|
|
|
|
L01XX18
|
Tiazofurine
|
|
|
|
|
L01XX19
|
Irinotecan
|
|
|
|
|
L01XX22
|
Alitretinoin
|
|
|
|
|
L01XX23
|
Mitotane
|
|
|
|
|
L01XX24
|
Pegaspargase
|
|
|
|
|
L01XX25
|
Bexarotene
|
|
|
|
|
L01XX27
|
Arsenic trioxide
|
|
|
|
|
L01XX29
|
Denileukin diftitox
|
|
|
|
|
L01XX32
|
Bortezomib
|
|
|
|
|
L01XX33
|
Celecoxib
|
|
|
|
|
L01XX35
|
Anagrelide
|
|
|
|
|
L01XX36
|
Oblimersen
|
|
|
|
|
L01XX37
|
Sitimagene ceradenovec
|
|
|
|
|
L01XX38
|
Vorinostat
|
|
|
|
|
L01XX39
|
Romidepsin
|
|
|
|
|
L01XX40
|
Omacetaxine mepesuccinate
|
|
|
|
|
L01XX41
|
Eribulin
|
|
|
|
|
L01XX42
|
Panobinostat
|
|
|
|
|
L01XX43
|
Vismodegib
|
|
|
|
L01XY
|
|
Combinations of antineoplastic agents
|
|
|
|
|
|
EMPTY
|
|
L02
|
|
|
|
Endocrine therapy
|
|
L03
|
|
|
|
Immunostimulants
|
|
L04
|
|
|
|
Immunosuppressants
|
M
|
|
|
|
|
Musculo-skeletal system
|
|
M01
|
|
|
|
Anti-inflammatory and antirheumatic products
|
|
|
M01A
|
|
|
Anti-inflammatory and antirheumatic products, non-steroids
|
|
|
|
M01AA
|
|
Butylpyrazolidines
|
|
|
|
M01AB
|
|
Acetic acid derivatives and related substances
|
|
|
|
|
M01AB01
|
Indometacin
|
|
|
|
|
M01AB02
|
Sulindac
|
|
|
|
|
M01AB03
|
Tolmetin
|
|
|
|
|
M01AB04
|
Zomepirac
|
|
|
|
|
M01AB05
|
Diclofenac
|
|
|
|
|
M01AB06
|
Alclofenac
|
|
|
|
|
M01AB07
|
Bumadizone
|
|
|
|
|
M01AB08
|
Etodolac
|
|
|
|
|
M01AB09
|
Lonazolac
|
|
|
|
|
M01AB10
|
Fentiazac
|
|
|
|
|
M01AB11
|
Acemetacin
|
|
|
|
|
M01AB12
|
Difenpiramide
|
|
|
|
|
M01AB13
|
Oxametacin
|
|
|
|
|
M01AB14
|
Proglumetacin
|
|
|
|
|
M01AB15
|
Ketorolac
|
|
|
|
|
M01AB16
|
Aceclofenac
|
|
|
|
|
M01AB17
|
Bufexamac
|
|
|
|
|
M01AB51
|
Indometacin, combinations
|
|
|
|
|
M01AB55
|
Diclofenac, combinations
|
|
|
|
M01AC
|
|
Oxicams
|
|
|
|
M01AE
|
|
Propionic acid derivatives
|
|
|
|
M01AG
|
|
Fenamates
|
|
|
|
M01AH
|
|
Coxibs
|
|
|
|
M01AX
|
|
Other anti-inflammatory and antirheumatic agents, non-steroids
|
|
|
|
|
M01AX01
|
Nabumetone
|
|
|
|
|
M01AX02
|
Niflumic acid
|
|
|
|
|
M01AX04
|
Azapropazone
|
|
|
|
|
M01AX05
|
Glucosamine
|
|
|
|
|
M01AX07
|
Benzydamine
|
|
|
|
|
M01AX12
|
Glucosaminoglycan polysulfate
|
|
|
|
|
M01AX13
|
Proquazone
|
|
|
|
|
M01AX14
|
Orgotein
|
|
|
|
|
M01AX17
|
Nimesulide
|
|
|
|
|
M01AX18
|
Feprazone
|
|
|
|
|
M01AX21
|
Diacerein
|
|
|
|
|
M01AX22
|
Morniflumate
|
|
|
|
|
M01AX23
|
Tenidap
|
|
|
|
|
M01AX24
|
Oxaceprol
|
|
|
|
|
M01AX25
|
Chondroitin sulfate
|
|
|
|
|
M01AX26
|
Avocado and soyabean oil, unsaponifiables
|
|
|
|
|
M01AX68
|
Feprazone, combinations
|
|
|
M01B
|
|
|
Anti-inflammatory/antirheumatic agents in combination
|
|
|
M01C
|
|
|
Specific antirheumatic agents
|
|
M02
|
|
|
|
Topical products for joint and muscular pain
|
|
|
M02A
|
|
|
Topical products for joint and muscular pain
|
|
|
|
M02AA
|
|
Anti-inflammatory preparations, non-steroids for topical use
|
|
|
|
|
M02AA01
|
Phenylbutazone
|
|
|
|
|
M02AA02
|
Mofebutazone
|
|
|
|
|
M02AA03
|
Clofezone
|
|
|
|
|
M02AA04
|
Oxyphenbutazone
|
|
|
|
|
M02AA05
|
Benzydamine
|
|
|
|
|
M02AA06
|
Etofenamate
|
|
|
|
|
M02AA07
|
Piroxicam
|
|
|
|
|
M02AA08
|
Felbinac
|
|
|
|
|
M02AA09
|
Bufexamac
|
|
|
|
|
M02AA10
|
Ketoprofen
|
|
|
|
|
M02AA11
|
Bendazac
|
|
|
|
|
M02AA12
|
Naproxen
|
|
|
|
|
M02AA13
|
Ibuprofen
|
|
|
|
|
M02AA14
|
Fentiazac
|
|
|
|
|
M02AA15
|
Diclofenac
|
|
|
|
|
M02AA16
|
Feprazone
|
|
|
|
|
M02AA17
|
Niflumic acid
|
|
|
|
|
M02AA18
|
Meclofenamic acid
|
|
|
|
|
M02AA19
|
Flurbiprofen
|
|
|
|
|
M02AA21
|
Tolmetin
|
|
|
|
|
M02AA22
|
Suxibuzone
|
|
|
|
|
M02AA23
|
Indometacin
|
|
|
|
|
M02AA24
|
Nifenazone
|
|
|
|
|
M02AA25
|
Aceclofenac
|
|
|
|
|
M02AA26
|
Nimesulide
|
|
|
|
M02AB
|
|
Capsaicin and similar agents
|
|
|
|
M02AC
|
|
Preparations with salicylic acid derivatives
|
|
|
|
M02AX
|
|
Other topical products for joint and muscular pain
|
|
M03
|
|
|
|
Muscle relaxants
|
|
M04
|
|
|
|
Antigout preparations
|
|
M05
|
|
|
|
Drugs for treatment of bone diseases
|
|
M09
|
|
|
|
Other drugs for disorders of the musculo-skeletal system
|
N
|
|
|
|
|
Nervous system
|
|
N01
|
|
|
|
Anesthetics
|
|
N02
|
|
|
|
Analgesics
|
|
N03
|
|
|
|
Antiepileptics
|
|
N04
|
|
|
|
Anti-parkinson drugs
|
|
N05
|
|
|
|
Psycholeptics
|
|
|
N05A
|
|
|
Antipsychotics
|
|
|
|
N05AA
|
|
Phenothiazines with aliphatic side-chain
|
|
|
|
N05AB
|
|
Phenothiazines with piperazine structure
|
|
|
|
N05AC
|
|
Phenothiazines with piperidine structure
|
|
|
|
N05AD
|
|
Butyrophenone derivatives
|
|
|
|
N05AE
|
|
Indole derivatives
|
|
|
|
N05AF
|
|
Thioxanthene derivative
|
|
|
|
N05AG
|
|
Diphenylbutylpiperidine derivatives
|
|
|
|
N05AH
|
|
Diazepines, oxazepines, thiazepines and oxepines
|
|
|
|
N05AL
|
|
Benzamides
|
|
|
|
N05AN
|
|
Lithium
|
|
|
|
N05AX
|
|
Other antipsychotics
|
|
|
|
|
N05AX07
|
Prothipendyl
|
|
|
|
|
N05AX08
|
Risperidone
|
|
|
|
|
N05AX10
|
Mosapramine
|
|
|
|
|
N05AX11
|
Zotepine
|
|
|
|
|
N05AX12
|
Aripiprazole
|
|
|
|
|
N05AX13
|
Paliperidone
|
|
|
|
|
N05AX14
|
Iloperidone
|
|
|
N05B
|
|
|
Anxiolytics
|
|
|
|
N05BA
|
|
Benzodiazepine derivatives
|
|
|
|
|
|
להשלים
|
|
|
N05C
|
|
|
Hypnotics and sedatives
|
|
N06
|
|
|
|
Psychoanaleptics
|
|
N07
|
|
|
|
Other nervous system drugs
|
P
|
|
|
|
|
Antiparasitic products, insecticides and repellents
|
|
P01
|
|
|
|
Antiprotozoals
|
|
P02
|
|
|
|
Anthelmintics
|
|
P03
|
|
|
|
Ectoparasiticides, including scabicides, insecticides and repellents
|
R
|
|
|
|
|
Respiratory system
|
|
R01
|
|
|
|
Nasal preparations
|
|
R02
|
|
|
|
Throat preparations
|
|
R03
|
|
|
|
Drugs for obstructive airway diseases
|
|
R05
|
|
|
|
Cough and cold preparations
|
|
R06
|
|
|
|
Antihistamines for systemic use
|
|
R07
|
|
|
|
Other respiratory system products
|
S
|
|
|
|
|
Sensory organs
|
|
S01
|
|
|
|
Ophthalmologicals
|
|
S02
|
|
|
|
Otologicals
|
|
S03
|
|
|
|
Ophthalmological and otological preparations
|
V
|
|
|
|
|
Various
|
|
V01
|
|
|
|
Allergens
|
|
V03
|
|
|
|
All other therapeutic products
|
|
V04
|
|
|
|
Diagnostic agents
|
|
V06
|
|
|
|
General nutrients
|
|
V07
|
|
|
|
All other non-therapeutic products
|
|
V08
|
|
|
|
Contrast media
|
|
V09
|
|
|
|
Diagnostic radiopharmaceuticals
|
|
V10
|
|
|
|
Therapeutic radiopharmaceuticals
|
|
V20
|
|
|
|
Surgical dressings
|